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Abstract
Guided tissue regeneration (GTR) to regenerate periodontal tissue involves placement of
a cell-occlusive barrier membrane functionally excluding the gingiva and associated oral
epithelium from the periodontal defect. Gingival connective tissue contains a rich
vascular plexus and is a source of progenitor cells which could contribute to periodontal
regeneration. We have investigated the use of a novel bioresorbable and bioactive
electrospun fibrous polycaprolactone (PCL) scaffold loaded with microspheres releasing
basic fibroblast growth factor (bFGF) to promote gingival connective tissue growth while
maintaining a barrier to the oral epithelium. Scaffolds supported an increase in human
gingival fibroblast cell number and mesenchymal cell infiltration in a bFGF dose
dependent manner while excluding oral epithelial cell penetration. Scaffold treatment
during early healing of rat gingival wounds showed good biocompatibility. This study
suggests that PCL electrospun scaffolds both with and without bFGF microspheres
represent a promising alternative to the current generation of GTR barrier membranes.
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Chapter 1

1

Introduction
1.1

Chapter Summary

Periodontal diseases are pathologies which affect the tissues supporting teeth and are
highly prevalent, affecting up to 90% of the world’s population (Pihlstrom, Michalowicz
et al. 2005). These supporting tissues are collectively termed the periodontium and
function as a unit to securely anchor each tooth into the jaw. The periodontium is
composed of four tissues; the gingiva, the periodontal ligament (PDL), cementum and the
alveolar bone (AAP 2001). Periodontitis, often known as “gum” disease, is a severe,
progressive inflammatory disease in which all of the tissues of the periodontium are
negatively affected. This condition is characterized by plaque formation, a loss of
connective tissue attachment to the tooth, formation of a periodontal pocket and
degeneration of the PDL, cementum and alveolar bone which, if left untreated, can lead
to tooth loss (AAP 2001, Pihlstrom, Michalowicz et al. 2005). Periodontitis is a
significant healthcare burden as it is estimated that over 47% of the adult US population
has periodontitis (Eke, Dye et al. 2012). Treatments aimed at removing the causative
bacterial agents are successful at halting the progression of the disease, but due to the
limited capacity of the periodontium for self-repair, usually result in minimal
regeneration of the lost tissues and can leave the patient with severe gingival recession
(Hughes, Ghuman et al. 2010). Therapeutic interventions such as guided tissue
regeneration (GTR) have been devised to attempt to regenerate the lost periodontal
structures.
GTR is a technique in which an occlusive barrier membrane is placed under the gingiva
over the tooth root to functionally exclude the gingival connective tissue and epithelium
from contacting the root thus providing the periodontal ligament and alveolar bone a
space into which they can regenerate (Nyman, Gottlow et al. 1982). Occlusive
membranes do not result in predictable or full regeneration of the lost periodontal
structures, indicating that significant improvements can be made (Bartold, McCulloch et
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al. 2000, Hughes, Ghuman et al. 2010). In addition, occlusive membranes exclude the
gingival connective tissue from the defect site. This is problematic as the gingival
connective tissue is a rich source of vasculature and contains progenitor cell populations
which can contribute to periodontal regeneration (Schroeder and Listgarten 1997,
Fournier, Larjava et al. 2013).
The overall focus of this work is the testing of a fibrous bioactive and bioresorbable
scaffold to recruit cells from the gingival connective tissue while maintaining a barrier to
oral epithelial cells. Electrospinning is a process that efficiently creates fibrous scaffolds
which are ideal for use in tissue regenerative applications due to their high surface area to
volume ratio and interconnected porosity allowing for cell infiltration and exchange of
nutrients and waste products throughout the construct (Dong, Liau et al. 2009).
Polycaprolactone (PCL) is a bioresorbable aliphatic polyester which can be electrospun
into a fibrous matrix and is advantageous for use due to its low cost, abundance, long
degradation time and biocompatibility (Dong, Liau et al. 2009). To confer bioactivity to
the scaffolds and promote in situ periodontal regeneration, basic fibroblast growth factor
(bFGF) will be added to the scaffold during the electrospinning process by
simultaneously electrospraying microspheres into the construct. The microspheres have a
core-shell structure with bFGF stabilized by heparin as the core encapsulated by a poly
(lactide-co-glycolide) (PLGA) shell allowing for sustained release of the growth factor
(Guo, Elliott et al. 2012).
bFGF is capable of stimulating the proliferation of fibroblast cells in a dose-dependent
manner, promoting angiogenesis, and accelerating oral wound healing (Gospodarowicz
1974, Murakami, Takayama et al. 2003, Oda, Kagami et al. 2004, Murakami and Simons
2008, Kitamura, Akamatsu et al. 2011). We hypothesize that scaffolds fabricated by
electrospinning the biocompatible polyester PCL into a fibrous scaffold loaded with
microspheres containing bFGF will promote gingival fibroblast proliferation while
maintaining a barrier to oral epithelial cells and promote the healing of full-thickness
gingival wounds in a rat model.
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1.2
1.2.1

The Periodontium
Structure and Function

The periodontium encompasses all of the structures that anchor teeth into the jaw. The
periodontium is comprised of both soft and hard connective tissues each of which plays a
critical role in the structural and functional maintenance of tooth attachment and function.
The periodontium is made up of four functional tissue components; the gingiva
(commonly referred to as gums), the periodontal ligament (PDL), the alveolar bone and
cementum (Bartold, Walsh et al. 2000) (Figure 1.1). Each of these tissues is unique in
terms of extracellular matrix (ECM) and cellular composition.
The primary support for the tooth is provided by bone, with each tooth anchored into the
jaw in a socket of mineralized alveolar bone through the PDL. The alveolar bone is made
up of an outer compact bone layer with an interior cancellous bone portion
(Hammarstrom and Lindskog 1985). The osteoblasts (bone forming cells) secrete the
organic bone matrix, termed osteoid, which is primarily type I collagen (Piperni,
Takamori et al. 2014). The secreted matrix is calcified and the resulting bone is 60%
inorganic material by weight with crystalline hydroxyapatite being the most abundant
inorganic constituent (Feng 2009). Bone remodeling occurs through the highly regulated
and coordinated actions of the bone depositing osteoblasts and the bone resorbing
osteoclasts (Charles and Aliprantis 2014).
The periodontal ligament is a dense connective tissue that forms the functional
attachment between the mineralized tissues of the cementum and the alveolar bone.
During mastication, the forces loaded on the teeth are dispersed through the PDL (Ho,
Marshall et al. 2007). The principle cell type of the PDL is the fibroblast which is found
in a matrix of principal fibers (large bundles of type I collagen that traverse the PDL and
are embedded in the bone and cementum) (Cho and Garant 2000). In addition, the PDL
matrix contains several small leucine rich proteoglycans (SLRPG) associated with the
collagen fibril bundles, including lumican, fibromodulin, decorin, and biglycan
(Matheson, Larjava et al. 2005).
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Figure 1.1 - Anatomy of the periodontium.
Periodontium refers to the tissues which are critical in attaching teeth to the jaw. A)
Schematic illustrating a cross sectional view of a tooth and surrounding tissue. Tissues of
the periodontium are labelled in blue and are shown in reference to the tooth. B)
Hematoxylin and eosin stained section of a rat molar and surrounding tissue. The tissues
of the periodontium are labelled as periodontal ligament (PDL), cementum (C), alveolar
bone (B) and the gingiva which is composed of connective tissue (CT) covered by oral
epithelium (OE). The gingiva attaches to and forms a tight seal with the tooth through
the junctional epithelium (JE) which merges with the sulcular epithelium (SE) in the
gingival sulcus. The tooth is composed of dentin (D) with an enamel crown, shown as an
enamel space (E) in histologic sections. The cementoenamel junction (CEJ) is a
landmark feature where the cementum covering the tooth root (R) meets the enamel.
Terminology regarding directionality associated with the tooth is such that coronal
indicates towards the crown of the tooth and apical indicates towards the apex of the root.
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Cementum is a thin layer of mineralized tissue found on the surface of the dentinal tooth
root where the tooth root interfaces with the PDL (Foster 2012). Cementum functions to
anchor the collagen fiber bundles of the PDL to the tooth root through structures termed
Sharpey’s fibers (Bosshardt and Selvi 1997). The organic component of cementum is
mainly type I collagen (>90%) with approximately 5% type III collagen (BirkedalHansen, Butler et al. 1977) and is formed by cementoblasts which are derived from
neural crest cells during development (ectomesenchymal origin) (Chai, Jiang et al. 2000).
The gingiva is composed of a type I collagen rich dense connective tissue with an
overlying epithelium and forms a soft connective tissue covering over the PDL, alveolar
bone, cementum, and tooth roots. Oral gingival epithelial cells (ectodermal origin) are
the main cell type of the epithelium; however, other cells may be seen such as
Langerhans cells, melanocytes and Merkel cells (Ramibri, Panzica et al. 1992, Barrett
and Raja 1997, Bartold, Walsh et al. 2000). The epithelium of the gingiva is divided into
three distinct anatomical regions which differ in their cellular organization, function and
keratin composition (Mackenzie, Rittman et al. 1991). These regions are defined as the
oral gingival, oral sulcular and junctional epithelia (Schroeder and Listgarten 1997).
Overall, the epithelia functions to prevent bacterial infiltration into the underlying
periodontium. The teeth present a unique challenge to this protective function in that the
tooth is not an appendage of the mucosa, but rather perforates through it. Thus, a tight
seal must be made between the hard tissue of the tooth and the epithelium of the gingiva.
This occurs through the junctional epithelium which attaches to the tooth from the
cementoenamel junction to the bottom of the gingival sulcus (Bosshardt and Lang 2005).
The junctional epithelium is a stratified, non-keratinizing epithelium which is bordered
by two basal lamina; an external basal lamina found between the epithelium and the
connective tissue and an internal basal lamina found between the epithelium and the
surface of the tooth (Sawada and Inoue 1996, Bosshardt and Lang 2005). The connective
tissue component of the gingiva is composed of gingival fibroblasts (mesenchymal
origin) residing within an extracellular matrix of collagen, mainly type I, and
proteoglycans including decorin, biglycan, versican, and CD44 (Bratt, Anderson et al.
1992, Larjava, Hakkinen et al. 1992, Hakkinen, Oksala et al. 1993). Collagen fibers of
the matrix show considerable organization into thick bundles and form the gingival
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supra-alveolar fiber apparatus which attaches to the tooth (Chavrier, Couble et al. 1984,
Bartold, Walsh et al. 2000). Together, the connective tissue and epithelium maintain
homeostasis of the periodontium by functionally excluding the oral environment from the
underlying structures. The integrity of the barrier can however be compromised
following injury, trauma or prolonged poor oral hygiene which then allows for invasion
of the tissues by microbial organisms (Schroeder and Listgarten 1997).

1.2.2

Periodontal Diseases

Periodontal diseases are broadly defined as pathologies that affect the periodontium.
These conditions can be inherited, but are usually acquired. Furthermore, periodontal
diseases are influenced by genetic, traumatic, developmental or inflammatory factors
(Pihlstrom, Michalowicz et al. 2005). However, the term periodontal disease is most
commonly used to refer to the inflammatory conditions in which inflammation of the
periodontium is caused by pathogenic bacteria in tooth plaque that accumulates on and
around the tooth surfaces (Armitage 2004, Pihlstrom, Michalowicz et al. 2005).
Periodontal diseases range in severity with the mildest form being gingivitis. Gingivitis
is mild inflammation that is confined to the gingiva and can be readily reversed by
removing the causative bacterial agents through routine oral hygiene (Pihlstrom,
Michalowicz et al. 2005). Although reversible, gingivitis is highly prevalent with more
than 82% of adolescents and 50% of adults in the United States being affected (Albandar
and Rams 2002). If gingivitis is allowed to persist, the condition progresses and can
develop into the more serious periodontitis (Albandar and Rams 2002).
Periodontitis affects all of the structures of the periodontium and leads to destruction of
the gingival connective tissue and the PDL, and resorption of the alveolar bone, which
can lead to loosening of the tooth and eventual tooth loss (AAP 2001, Pihlstrom,
Michalowicz et al. 2005). Periodontitis develops when bacterial components and their
products which have accumulated around the teeth infiltrate the gingival epithelium into
the connective tissue and cause a persistent host inflammatory response (Page,
Offenbacher et al. 1997). The tight seal maintained by the junctional epithelium is
compromised, exposing the underlying periodontium to the more than 500 bacterial
species present in the oral cavity (Moore and Moore 1994, Bosshardt and Lang 2005).
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The loss of connective tissue attachment results in the formation of a periodontal pocket
which becomes lined with gingival epithelium and further accumulates bacteria and
plaque (Page, Offenbacher et al. 1997). The pathogenesis is, in part, mediated through
bacterial release of endotoxins and proteases which break down the tissues of the
periodontium (Socransky and Haffajee 1994). Of even greater significance is that the
persistence of bacteria activates the host immune inflammatory response, and if
sustained, will result in release of proteolytic enzymes which further contribute to tissue
breakdown (Pihlstrom, Michalowicz et al. 2005). During the inflammatory response,
macrophages become activated and release several factors including interleukin 1β,
tumour necrosis factor α, matrix metalloproteinases, and prostaglandin E2 (Page,
Offenbacher et al. 1997). Gingival fibroblasts are activated to produce matrix
metalloproteinases and prostaglandin E2 in response to interleukin 1β and tumour
necrosis factor α (Page, Offenbacher et al. 1997). Matrix metalloproteinases mediate the
destruction of the extracellular matrix components and prostaglandin E2 mediates
resorption of the alveolar bone (Page, Offenbacher et al. 1997).
Periodontitis has a high prevalence rate. Data from the 2009 and 2010 National Health
and Nutrition Examination Survey estimated that 47% of the adult U.S. population is
affected by periodontitis (Eke, Dye et al. 2012). Several factors predispose an individual
to being affected by periodontal diseases including: poor oral hygiene, tobacco use,
stress, diabetes, and age (Petersen and Ogawa 2005, Kinane, Bouchard et al. 2008).
Periodontitis can also have interactions with other systemic conditions. Clinical studies
suggest that periodontitis is more severe in patients with uncontrolled diabetes mellitus
and can negatively impact cardiovascular events in susceptible individuals due to the high
inflammatory burden associated with periodontitis (Kinane, Bouchard et al. 2008).
In addition to its high prevalence rate, the major concern with periodontitis is the limited
ability of the periodontium to regenerate even after removal of the causative bacterial
agents (Pihlstrom, Michalowicz et al. 2005, Hughes, Ghuman et al. 2010). Non-surgical
treatment of periodontitis involves the removal of plaque and bacteria from around the
tooth, however this only serves to stop the progression of the disease with little
appreciable regeneration of the lost structures (Pihlstrom, Michalowicz et al. 2005,
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Hughes, Ghuman et al. 2010). Following treatment, inflammation and swelling of the
gingival tissue subsides, but apical migration of the epithelium and tissue shrinkage result
in gingival recession (Tugnait and Clerehugh 2001).
When the gingival margin is located apical to the normal location at the cementoenamel
junction, gingival recession is diagnosed (AAP 2001). In addition to being caused by
periodontitis, gingival recession can be a result of trauma, poor tooth alignment, or
thinning or reduction of the alveolar bone (Watson 1984, Chambrone and Chambrone
2003). Gingival recession can also affect individuals with good oral hygiene; a
prevalence rate of 25% was evident in a sample population who had good oral hygiene
and received regular dental care (Seritm, Wennstrom et al. 1994). The prevalence of
gingival recession is high, with more than 50% of the population having at least one site
of gingival recession (Kassab and Cohen 2003). Gingival recession may be present
without being apparent to the patient, however other patients with recessions may
experience pain and root hypersensitivity, fear over tooth loss, and esthetic concerns
(Kassab and Cohen 2003). Exposure of the tooth root to the oral cavity due to gingival
recession causes tooth sensitivity and may make the root more susceptible to abrasion
and caries which is damaging to the health and survival of the tooth (Kassab and Cohen
2003). Gingival recession resultant from periodontitis indicates that the healing response
is inadequate to restore the correct functional and anatomical structure of the
periodontium.

1.3
1.3.1

Gingival Wound Healing
Connective Tissue

The basic stages of wound healing that take place during cutaneous wound repair also
occur during healing of the oral mucosa. Three sequential, but overlapping, phases of
wound healing are required: inflammatory phase, granulation tissue formation and matrix
deposition and remodeling (Wikesjo and Selvi 1999). Immediately following connective
tissue injury, plasma proteins from the blood, primarily fibrinogen, adhere to wound
surfaces and the tooth root in preparation for the formation of a fibrin clot (Wikesjo and
Selvi 1999, Polimeni, Xiropaidis et al. 2006). Within hours of injury, a pro-
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inflammatory response is initiated, characterized by infiltration of neutrophils and
monocytes to phagocytose cellular debris from the damaged and necrotic areas of the
tissues (Polimeni, Xiropaidis et al. 2006). Up to three days following injury,
inflammation persists with neutrophil infiltration gradually subsiding as macrophage
influx becomes predominant. The phenotype of the macrophages switches to promote
repair through the release of growth factors such as transforming growth factor-β1 (TGFβ1) which enables the transition to development of granulation tissue and the proliferative
stage of repair (Leibovich and Ross 1975, Wikesjo and Selvi 1999). As granulation
tissue forms up to day seven following injury, fibroblasts and endothelial cells migrate
into the wound area and proliferate, a provisional matrix is deposited, and angiogenesis
occurs (Wikesjo and Selvi 1999, Polimeni, Xiropaidis et al. 2006). Fibroblast migration
into the granulation tissue requires downregulation of integrins for collagen attachment
(α2β1) and upregulation of integrins for interaction with components of the provisional
matrix: fibrin (αVβ3), fibronectin (α4β1) and vitronectin (αVβ5) (Aukhil 2000).
Following the events in the initial seven days post-injury, the wound enters the matrix
remodeling phase wherein the granulation tissue matrix is remodeled into a more
collagen rich, mature and stable matrix followed by the appearance of myofibroblasts
which contract the wound (Wikesjo and Selvi 1999, Polimeni, Xiropaidis et al. 2006).
Although the initial steps of wound healing are essentially analogous to most soft tissue
healing, proper periodontal healing requires the connective tissue to make adequate
adhesion to the tooth root through anchorage of collagen fibers to the cementum
(Wikesjo and Selvi 1999).

1.3.2

Epithelial Component

Within hours of a gingival wound forming, basal epithelial cells start to proliferate and
migrate into the fibrin clot in the wound area (Polimeni, Xiropaidis et al. 2006). In
uninjured tissue, basal epithelial cells are attached to the basal lamina through integrin
α6β4 attachment to laminin (Aukhil 2000). To initiate migration in response to injury the
epithelial cells must first break hemidesmosome connections with the basal lamina and
express integrins suitable for migration through the fibrin clot (Borradori and Sonnenberg
1999, Aukhil 2000). Migrating epithelial cells start to express integrins α5β1
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(fibronectin), αVβ6 (tenascin), αVβ5 (vitronectin) and reorganize their distribution of
integrin α2β1 (collagen) allowing for migration over wound debris and the provisional
wound matrix (Aukhil 2000). Migrating epithelial cells also upregulate tissue-type
plasminogen activator and urokinase-type plasminogen activator which activate the
plasminogen in the fibrin clot to plasmin allowing for the breakdown of the clot, thus
creating a path through which migration can occur (Martin 1997). Once the wound is reepithelialized a new basal lamina forms and epithelial cells return to their original
phenotype (Aukhil 2000). The epithelium must also reform the junctional and sulcular
epithelium found adjacent to the tooth. The junctional epithelium appears to be
regenerated from undifferentiated cells from the sulcular epithelium (Sabag, Mery et al.
1984). Formation of a long junctional epithelium can occur following gingival wounding
where the epithelium is found migrating apically along the tooth root hindering the
formation of connective tissue attachment to the tooth root. This occurs as a result of the
epithelium migrating faster than the formation and attachment of new connective tissue to
the tooth root (Bartold, Walsh et al. 2000). The formation of this periodontal pocket is
one of the major problems in the regeneration of gingival connective tissue and must be
prevented.
Although the gingiva possesses considerable healing capacity following injury, repair
following the repeated inflammatory response associated with inflammatory periodontal
diseases results in tissue shrinkage, fibrosis and gingival recession (Hughes, Ghuman et
al. 2010). This in combination with the formation of a periodontal pocket prevents
proper anatomical self-repair of the periodontium thus requiring periodontal therapeutic
intervention (Pihlstrom, Michalowicz et al. 2005).

1.4
1.4.1

Periodontal Disease Treatments
Periodontal Plastic Surgery

Periodontal plastic surgery refers to surgical techniques and procedures used to treat and
correct several types of periodontal defects, including surgeries to correct gingival
recession (Miller 1988). There are several procedures which can be used to correct
gingival recession defects, such as coronally advanced flaps, free gingival grafts, laterally
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repositioned flaps and subepithelial connective tissue grafts (SCTGs) (Chambrone,
Sukekava et al. 2010). SCTGs are considered the gold-standard for the treatment of
gingival recession defects (Chambrone, Chambrone et al. 2008, Chambrone, Sukekava et
al. 2010). In this procedure, a palatal donor site is raised and a connective tissue graft
larger than the recession site is removed. The flap created at the donor site must then be
sutured back into place. At the recipient site, a flap is raised with the harvested
connective tissue graft placed over the exposed tooth root and sutured into place
following cleaning of the root surface (Langer and Langer 1985, Raetzke 1985).
Although considered the gold-standard, SCTG procedures are associated with several
drawbacks mainly due to the need for a second surgical donor site. The donor site is
associated with pain and discomfort, bleeding, morbidity, and the availability of donor
tissue in the palate is extremely limited (Liu, Mao et al. 2011). In addition, as oral
epithelial tissue proliferates faster than connective tissue or graft tissue, it commonly
migrates down the tooth root forming a long junctional epithelium and impairing the
ability of the connective tissue or graft to attach and provide root coverage (Bartold,
McCulloch et al. 2000).

1.4.2

Guided Tissue Regeneration

Guided tissue regeneration (GTR) is a technique that involves the placement of a barrier
membrane into the periodontal defect site immediately under the gingival tissue forming
a physical gap or barrier to exclude epithelium from populating the damaged site;
maintaining space for the PDL and alveolar bone to regenerate into (Fu, Su et al. 2012)
(Figure 1.2). This technique was first introduced in 1982 when Nyman and colleagues
(Nyman, Gottlow et al. 1982) used a Millipore filter as a membrane in a non-human
primate model of periodontitis to regenerate periodontal structures and remains a
routinely used surgery by periodontists. The use of barrier membranes for periodontal
repair overcomes the drawbacks associated with SCTGs in that it does not rely on the
availability of donor tissue.
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Figure 1.2 - Guided tissue regeneration.
We propose the use of a PCL electrospun fibrous scaffold membrane as an alternative to
the current cell-occlusive GTR membranes. Membranes are placed under the gingival
connective tissue against the root of the tooth to prevent the apical migration of the oral
epithelium. To promote PDL cell infiltration and bone regeneration a second scaffold or
material can be placed into the periodontal defect.
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GTR membranes must fulfill certain characteristic properties including biocompatibility
and safety, space maintenance, ease of use, and cell exclusion (Aurer and Jorgic-Srdjak
2005). The concept of space maintenance and cell exclusion is such that the gingiva is
excluded from the defect site providing the periodontal ligament cells with a space
adjacent to the tooth into which they can selectively repopulate the defect (Gottlow,
Nyman et al. 1986). As described below, several types of materials are used clinically as
a barrier membrane. The types of membranes used can be classified into non-resorbable;
those requiring surgical removal following periodontal regeneration, or resorbable; those
which are degraded during the healing process. Resorbable membranes can be fabricated
from natural or synthetic materials, as discussed in detail in the following sections.

1.4.2.1

Non-Resorbable Membranes - Gore-Tex®

Non-resorbable membranes maintain their structure and integrity throughout the healing
process, with the most commonly used material being Gore-Tex®. Gore-Tex® expanded
polytetrafluoroethylene (ePTFE) membranes were the first non-resorbable membranes
approved for clinical use (Aurer and Jorgic-Srdjak 2005). ePTFE is manufactured from
the inert and biocompatible fluorocarbon polymer polytetrafluoroethylene under tensile
strength creating a porous and fibrous microstructured material (Aurer and Jorgic-Srdjak
2005). Although the use of these membranes show improvements in periodontal clinical
parameters, complete regeneration remains a challenge (Gottlow, Nyman et al. 1986,
Stahl, Froum et al. 1990, Kersten, Chamberlain et al. 1992, Wadhawan, Gowda et al.
2012). These occlusal membranes provide adequate space maintenance and cell
exclusion in the defect site, but as they are non-resorbable, a second surgery is required to
retrieve the membrane. This is not ideal as it increases surgical time for the patient,
increases the cost of the GTR procedure and adds additional surgical trauma to any newly
formed periodontal tissue (Gottlow 1993).

1.4.2.2

Biodegradable and Bioresorbable Membranes

To eliminate the need for a second surgery to remove membranes following healing,
resorbable membranes for periodontal regeneration were developed. These membranes
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act as a space making barrier during the healing period and following the establishment
of new periodontal attachment the material degrades, ideally without affecting the
regeneration of the periodontal tissues (Gottlow 1993). While natural materials have
been investigated for use as membranes, their biomechanical properties are not optimal
for an active biomechanical environment where aggressive oral epithelial migration
occurs. The material must have resilience and strength which membranes made from
natural material rarely possess (Aurer and Jorgic-Srdjak 2005). Several synthetic
biomaterials have now been developed for use as barrier membranes. Synthetic polymers
are an attractive option due to their low cost, abundance, ease of fabrication and large
customization potential. Polylactic acid (PLA), polyglycolic acid (PGA), PCL and their
copolymers have been widely investigated. These three polyesters have been approved
by the U.S. Food and Drug Administration for use in medical applications such as
bioabsorbable sutures and applications for drug delivery (Dong, Liau et al. 2009).

1.4.2.2.1

Collagen

Collagen membranes were developed for GTR applications due to their inherent
biocompatibility and their chemotactic properties for fibroblasts (Postlethwaite, M. et al.
1978, Rothamel, Schwarz et al. 2004), examples of which include: BioMend® and BioGide®. Collagen membranes were found to support connective tissue attachment and
prevent epithelial migration along the tooth root in canine periodontal defects
(Blumenthal 1988, Pitaru, Tal et al. 1989) and were found to be as effective as ePTFE
membranes at restoring clinical periodontal attachment in clinical studies (Blumenthal
1988, Pitaru, Tal et al. 1989, Tatakis, Promsudthi et al. 1999). The degradation of
collagen membranes occurs through the enzymatic activity of inflammatory cells and
degrade within 4-8 weeks (Blumenthal 1988, Pitaru, Tal et al. 1989, Tatakis, Promsudthi
et al. 1999). For effective space maintenance in the defect site the membrane must
withstand the forces created by flap placement and associated with mastication (Tatakis,
Promsudthi et al. 1999). The failure of collagen membranes to withstand such forces,
along with their rapid degradation in particular when exposed to enzymes associated with
saliva and the inflammatory response may contribute to their variability in regenerating
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periodontal tissue and the inability to promote complete periodontal defect fill (Pitaru, Ta
et al. 1987, Bunyaratavej and Wang 2001).

1.4.2.2.2

Polylactic Acid

PLA is a synthetic poly (α-hydroxy acid) which is manufactured by catalytic
polymerization of lactic acid monomers (Tatakis, Promsudthi et al. 1999). In contrast to
collagen which degrades by enzymatic activity, poly (α-hydroxy acids) are degraded by
hydrolysis with the resulting degradation products being metabolized by the citric acid
(Kreb) cycle to produce water and carbon dioxide (Tatakis, Promsudthi et al. 1999). PLA
hydrolysis is relatively slow and produces monomers of lactic acid, linear dimers and
other oligomers (Marcato, Paganetto et al. 1996) which can be cytotoxic in high
concentrations, although the polymers themselves are biocompatible in vitro (Ignatius
and Claes 1996). Although PLA is biocompatible in vitro, implantation into periodontal
defects initiates an inflammatory response at 4 weeks (Wikesjö and Nilvéus 1990) and
severe bone resorption was observed 4 months following implantation (Mau, Cheng et al.
2012). This suggests that PLA is not an ideal synthetic biomaterial for GTR membranes.

1.4.2.2.3

Polyglycolic Acid

PGA has a relatively fast degradation rate compared to other synthetic aliphatic
polyesters (Dong, Liau et al. 2009). PGA is used clinically for pins, screws, rods and
implants in orthopedic applications. PGA implants in bone are associated with localized
inflammation which does not compromise repair, however this inflammatory response
may be problematic when using PGA for soft tissue wound repair or regenerative
applications where the tissue is already inflamed (Bostman, Hirvensalo et al. 1990,
Ceonzo, Gaynor et al. 2006). Subcutaneous PGA polymer implants have been associated
with an acute inflammatory response, the magnitude of which is proportional to the
degradation time of the polymer, with faster degradation times inducing greater
inflammatory responses (Burdick, Padera et al. 2002). As with PLA, high concentrations
of the degradation products can be cytotoxic and damage surrounding tissue (Bostman,
Hirvensalo et al. 1990, Ashammakhi and Rokkanen 1997, Ceonzo, Gaynor et al. 2006,
Dong, Liau et al. 2009). The inflammatory response to PGA may affect matrix
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production and ultimately the integrity of the healing tissue (Kojima, Bonassar et al.
2002). To prolong the degradation time and make PGA more suitable in terms of
providing adequate support for regenerating periodontal tissue and reducing the
inflammatory response for membranous tissue repair applications, PGA is often
combined with PLA to form the copolymer poly (lactide-co-glycolide) (PLGA) which
has an intermediate degradation time between the two polymers. Gingival fibroblasts
cultured on PLGA membranes in vitro had decreased proliferation compared to gingival
fibroblasts cultured on collagen membranes, indicating that collagen membranes may
preferentially promote gingival tissue repair (Hakki, Korkusuz et al. 2013).
Barrier membranes currently used for GTR that are completely occlusal do not work
well. As described above, the use of barrier membranes in periodontal procedures does
not provide predictable or full regeneration of the damaged periodontium, making it clear
that several improvements need to be made to the GTR technique (Kersten, Chamberlain
et al. 1992, Greenstein and Caton 1993, Ivanovski 2009, Hughes, Ghuman et al. 2010).
Space provision by GTR membranes appears to be a requirement for facilitating
periodontal regeneration, whereas tissue occlusion does not appear to be a necessity
(Wikesjo, Lim et al. 2003, Polimeni, Albandar et al. 2005). The use of an occlusive
membrane which excludes gingival connective tissue from a regenerating periodontal
defect is less than ideal as the gingiva contains a rich vascular plexus and is a potential
source of progenitor cells (Schroeder and Listgarten 1997, Fournier, Larjava et al. 2013).
A new generation of biomaterials needs to be developed and investigated for improved
GTR. One potential improvement is developing a fibrous, selectively occlusive
biomaterial scaffold membrane as an alternative to the current occlusal barrier
membranes.

1.4.3

Scaffold Membrane-Mediated Periodontal Regeneration

Scaffold membrane-mediated tissue regeneration is a strategy that is focused on
promoting regeneration of the normal tissue architecture to restore tissue function
through the use of a specifically designed biomaterial scaffold. This technique uses
biocompatible, resorbable biomaterial scaffold membranes fabricated to act as a
supportive three dimensional matrix, as opposed to cell-occlusive barrier membranes
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used currently for GTR. Ideally these scaffolds can mimic the natural fibrous structure of
the ECM, facilitating cell attachment and subsequent infiltration to promote the formation
of a functional cellular and vascular connective tissue attachment to the tooth root while
acting as a barrier for unfavourable cells, specifically epithelial cells (Schroeder and
Listgarten 1997, Sun, Qu et al. 2012). The scaffolds can also be engineered to
incorporate growth factors that allow for their controlled and sustained release in the
defect site (Kaigler, Cirelli et al. 2006, Barnes, Sell et al. 2007, Kao, Murakami et al.
2009).
Several scaffold materials have been tested for periodontal tissue healing applications
(Nakahara, Nakamura et al. 2003, Mohammadi, Shokrgozar et al. 2007, Jansen, KuijpersJagtman et al. 2008, Ayvazyan, Morimoto et al. 2011, Lotfi, Shokrgozar et al. 2011).
Collagen scaffolds were shown to be biocompatible in palatal wound healing applications
(Jansen, Kuijpers-Jagtman et al. 2008, Ayvazyan, Morimoto et al. 2011); however, due to
the requirement for mechanical stability in periodontal defects collagen scaffolds are not
ideal. Chitosan scaffolds, created by alkaline deacetylation of chitin (Akncbay, Senel et
al. 2007), and collagen scaffolds seeded with gingival fibroblasts increased the width of
keratinized gingival tissue in a canine model and in a clinical setting, respectively
(Mohammadi, Shokrgozar et al. 2007, Lotfi, Shokrgozar et al. 2011). This method,
however, requires a separate initial surgery for the harvesting of gingival fibroblasts and
requires ex vivo culture of the cells thus increasing the time, cost, and complexity of such
a procedure (Sun, Qu et al. 2012). Advances in the field of materials engineering make it
possible to design biofunctional biomaterial scaffolds which can be used to recruit
endogenous cells surrounding the defect site to promote in situ periodontal tissue
regeneration (Sun, Qu et al. 2012), which is the focus of this thesis.

1.4.3.1

Scaffold Fabrication

Development of optimal scaffolds requires: 1) selection of the appropriate material, 2)
fabrication of the appropriate structural architecture, and 3) addition of appropriate
biological signals, such as growth factors. Synthetic polyesters have been widely studied
for use in biomaterial scaffolds due to their availability and abundance, ease of
fabrication, customizability in terms of strength and degradation rate, and their
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biocompatibility and biodegradability characteristics. One particularly attractive property
of synthetic polymers is that they can be electrospun to create structures similar in size to
native ECM.

1.4.3.2

Electrospinning

Electrospinning is a process which can be used to fabricate fiber-based constructs from
both natural and synthetic polymers. The polymer is dissolved in a solvent and the
resulting solution is charged. A collection plate is oppositely charged and the polymer
solution is drawn into fibers by static electricity. As the solvent evaporates, the solid
polymer fibrous structure is left behind (Kumbar, James et al. 2008). This technique
allows fabrication of scaffolds which closely mimic the fibrous nature of the ECM. The
fibers produced by electrospinning are non-woven and have an interconnected porosity
allowing for cells to interact with the fibers while permitting cell infiltration throughout
the porous scaffold network and maintaining nutrient and waste exchange within the
scaffold (Dong, Liau et al. 2009).
The process of electrospinning has several advantages over other methods for scaffold
fabrication such as phase separation and self-assembly. Electrospinning is able to be
carried out in the laboratory setting but is scalable and can be adapted to large scale
processing, it is cost effective, convenient, and the diameter and alignment of the fibers is
able to be manipulated (Murugan and Ramakrishna 2007). The electrospinning apparatus
can also be set up to produce different nanofibrous structures such as aligned nanofibers,
tubular structures, and core-shell structures (Dong, Liau et al. 2009).
Several natural and synthetic materials have been electrospun into fibrous scaffolds.
Natural materials which have been electrospun include collagen, chitosan, agarose, and
alginate (Matthews, Wnek et al. 2002, Bhattarai, Edmondson et al. 2005, Shu-Hua Teng,
Peng Wang et al. 2009, Bonino, Krebs et al. 2011). Although these materials are capable
of being electrospun into fibrous scaffold membranes, their weak mechanical properties
and short degradation time limit their use for GTR membrane applications where they are
required to withstand the tissue tension forces associated with flap placement following
surgery and forces transmitted through the flaps from mastication (Tatakis, Promsudthi et
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al. 1999, Li, Laurencin et al. 2002, Teo, He et al. 2006). Synthetic polymers offer greater
mechanical stability compared to natural polymers. Synthetic polymers which have been
electrospun include PLA, PGA, and PCL and their copolymers (Huang, Zhang et al.
2003).

1.4.3.3

Polycaprolactone

PCL is a bioresorbable, aliphatic polyester with a molecular weight of 80,000 and a
relatively long degradation time compared to other synthetic polyesters, making it
suitable for space provision in GTR applications (Lam, Hutmacher et al. 2009). PCL is
quite stable during in vitro hydrolysis testing however shows a faster degradation rate by
microorganisms and enzymes (Zeng, Chen et al. 2004, Dong, Liau et al. 2009). The
degradation of PCL occurs in two stages. The first is non-enzymatic bulk hydrolysis in
which the carboxylic acid end groups autocatalyze the hydrolysis of the ester linkages
decreasing the molecular weight of the polymer without a decrease in weight
(Woodward, Brewer et al. 1985). Once the molecular weight of the polymer decreases to
5,000 weight loss occurs as the oligomeric species produced become small enough to
diffuse away from the bulk polymer (Woodward, Brewer et al. 1985). In the second
stage, low molecular weight PCL particles are ingested by neutrophils, macrophages,
giant cells and to a lesser extent, fibroblasts in vivo (Woodward, Brewer et al. 1985).
PCL fibrous scaffolds were found to have a faster degradation rate in vivo compared to in
vitro with smaller diameter fibers degrading faster than larger diameter fibers (Bölgen,
Menceloglu et al. 2005). Implantation of PCL scaffold matrices in both intramuscular
and subcutaneous sites were found to be biocompatible and did not elicit a negative host
response at 3 and 6 months post implantation (Lam, Hutmacher et al. 2009). This is in
contrast to the inflammatory response observed with PLA and PGA membranes, as
mentioned previously. Due to its long degradation time and biocompatibility, we
hypothesize that PCL is an appropriate material for fabrication of electrospun fibrous
scaffolds for periodontal regenerative applications. While fibrous PCL scaffolds can be
made to mimic the structural architecture of the ECM, this polymer lacks bioactivity,
which can impair tissue response.
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1.4.3.4

Enhancing Scaffold Bioactivity

Growth factors play important roles in the wound healing process, including the induction of
cell migration, proliferation and differentiation. Several studies have found the delivery of
growth factors to periodontal defect sites to be advantageous and promote regeneration
(Howell, Fiorellini et al. 1997, Oda, Kagami et al. 2004, Nemcovsky, Zahavi et al. 2006, Fu,
Su et al. 2012). The application of growth factors has had limited clinical success, due to the
rapid diffusion and degradation of topically applied growth factors, their short half-lives, and
the need to be administered in large doses (Kaigler, Cirelli et al. 2006, Hughes, Ghuman et al.
2010). There is a clear need for a more sustained method of delivery. Our aim is to create a
bioactive PCL electrospun fibrous scaffold that can be used for applications in periodontal
regeneration.

1.4.3.4.1

Electrospraying Core-Shell Microspheres

To confer bioactivity to the PCL electrospun fibrous scaffolds growth factors will be
delivered in the form of core-shell structured microspheres loaded into the fibrous
structure of the scaffold. Incorporation of growth factors into the scaffolds using this
method will allow for controlled and temporally sustained release of the growth factor.
Core-shell structures are produced by a coaxial electrospraying process wherein two
streams of materials are combined; an inner nozzle, containing the core material solution,
and an outer nozzle containing the shell material solution (Hwang, Jeong et al. 2008).
Coaxial electrospraying can create uniform sized microspheres with an outer polymer
shell and inner colloid core (Hwang, Jeong et al. 2008). As the outer shell material
degrades the inner core material is released in a controlled and sustained manner (Wu,
Liao et al. 2010). By combining the electrospraying and electrospinning processes, the
microspheres can be uniformly distributed within the scaffold (Guo, Elliott et al. 2012).
Due to its relatively fast degradation rate and biocompatibility when used in moderation,
PLGA was chosen as the material for the shell structure.

1.4.4

Biological Agents for Periodontal and Gingival Repair

Several growth factors have been investigated for use in periodontal tissue repair,
including platelet derived growth factor (PDGF), transforming growth factor-β1 (TGF-
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β1) and bone morphogenetic protein-2 (BMP-2). While PDGF and TGF-β1 do stimulate
the proliferation of gingival fibroblasts (Dennison, Vallone et al. 1994), the effect of
TGF-β1 in particular on gingival tissue may promote fibrosis and scar formation (Raja,
Byakod et al. 2009, Thompson, Hamilton et al. 2010). BMP-2 is strongly osteogenic,
however it is less than ideal for use due to its high cost, potential to cause root resorption
and ankyloses and its cytotoxic effects on PDL cells (Wikesjo, Guglielmoni et al. 1999,
Ryoo, Lee et al. 2006, Muthukuru 2013). For these reasons and those listed below, we
have focused our research program on bFGF. Murakami and colleagues (Murakami,
Takayama et al. 1999, Murakami, Takayama et al. 2003) were able to regenerate
periodontal structures in beagle dogs with experimentally induced periodontitis following
topical application of recombinant bFGF. Topical application of bFGF was assessed in a
large phase II clinical trial and found to be effective at regenerating the alveolar bone of
patients with periodontitis, however did not result in gain of clinical attachment
compared to vehicle alone (Kitamura, Akamatsu et al. 2011). Since bFGF is a potent
mitogen of mesenchymal cells and promotes wound healing, as described below, we
hypothesize that the sustained release of bFGF from PCL electrospun GTR scaffolds will
be effective at promoting the regeneration of clinical attachment.

1.5
1.5.1

Basic Fibroblast Growth Factor
General Structure and Function

Basic fibroblast growth factor was first identified in brain and pituitary extracts based on
its effects on the proliferation of 3T3 fibroblast cells (Gospodarowicz 1974). Human
bFGF was initially thought to be synthesized as a 155 amino acid protein which shares a
high degree of sequence homology (98.7%) with bovine bFGF indicating that it is highly
conserved across species (Abraham, Whang et al. 1986). Human bFGF is encoded by
one gene (FGFB) mapped to chromosome 4 (Abraham, Whang et al. 1986, Mergia, Eddy
et al. 1986). bFGF has since been identified as an 18 kDa protein with several high
molecular weight (HMW) (22-24 kDa) translational variants (Moscatelli, JosephSilverstein et al. 1987, Florkiewicz and Sommer 1989). Crystallographic analysis of the
bFGF protein revealed that the structure is entirely composed of β-sheets (Zhang,
Cousens et al. 1991). The tertiary structure of bFGF is composed of three 4-stranded β-
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meander motifs to create a barrel which is closed at the animo- and carboxy-terminus
(Zhang, Cousens et al. 1991). 18 kDa bFGF is primarily found in the cytosol and
increases cell growth and migration, whereas HMW bFGF is primarily localized to the
nucleus and increases cell growth but not migration and is required for cell growth in low
serum conditions (Renko, Quarto et al. 1990, Bikfalvi, Klein et al. 1995).
In physiological systems, heparin or heparan sulfate proteoglycans protect bFGF from
denaturation by binding to basic residues in the tenth and eleventh β strand of bFGF and
are required for bFGF to activate fibroblast growth factor receptor (FGFR) tyrosine
kinases (Rapraeger, Krufka et al. 1991, Kan, Wang et al. 1993, Nissen, Shankar et al.
1999, Faham, Linhardtt et al. 1998). Five FGFRs (FGFR 1-5) have been identified with
bFGF binding with highest affinity to FGFR1 and FGFR2 (Mansukhani, Moscatelli et al.
1990, Mansukhani, Dell'Era et al. 1992, Ornitz, Xu et al. 1996, Laestander and Engstrom
2014). Upon activation, FGFR tyrosine kinases dimerize and become
autophosphorylated (Bellot, Crumley et al. 1991). Several autophosphorylation sites in
FGF receptor tyrosine kinase 1 (FGFR1) have been identified including Tyr-463, Tyr583, Tyr-585, Tyr-653, Tyr-654, Tyr 730 and Tyr-766 (Mohammadi, Dikic et al. 1996).
Autophosphorylation of Tyr-766 causes association with phospholipase Cγ which
catalyses the hydrolysis of phosphatidylinositol into diacylglycerol and free inositol
phosphate which in turn activates protein kinase C to increase intracellular calcium,
affecting cytoskeletal organization (Peters, Marie et al. 1992, Laestander and Engstrom
2014). Autophosphorylation on Tyr-653 and Tyr-654 is required for the biological
activity of the receptor and may activate the Ras signaling pathway through
phosphorylation of Shc or a 90 kDa protein (pp90) (Mohammadi, Dikic et al. 1996).
Activated FGFR activates the docking protein FGFR substrate 2α which complexes with
the adaptor protein Grb2, tyrosine phosphatase Shp2 and docking protein GAB1
(Laestander and Engstrom 2014). Guanine nucleotide exchange factor SOS binds to
Grb2 and subsequently activates Ras-Mitogen activated protein kinase which through
interaction with intracellular kinases and transcription factors ultimately results in
regulation of gene expression, mainly with mitogenic effects (Laestander and Engstrom
2014).
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1.5.2

Angiogenesis

bFGF is a potent modulator of angiogenesis. Angiogenesis requires the migration of
endothelial cells and bFGF is one of the regulators of the migration of several types of
endothelial cells. Endothelial cells synthesize bFGF and upregulate the synthesis and
cytoplasmic stores during migration (Biro, Yu et al. 1994). Prior to DNA synthesis,
bFGF accumulates in the nucleus of endothelial cells (Biro, Yu et al. 1994). Exogenous
bFGF also plays a role in endothelial cell migration with the addition of bFGF to in vitro
cultures enhancing migration and the addition of antibodies to bFGF inhibiting migration
(Biro, Yu et al. 1994). bFGF induces the expression of another potent angiogenic factor,
vascular endothelial growth factor (VEGF), in endothelial cells through both autocrine
and paracrine mechanisms (Seghezzi, Patel et al. 1998). The angiogenic effects of bFGF
in vivo are modulated through VEGF suggesting that bFGF acts upstream of VEGF in the
process of angiogenesis (Seghezzi, Patel et al. 1998, Murakami and Simons 2008).

1.5.3

Chemotaxis

The formation of granulation tissue at a wound site requires the migration of fibroblasts
from the surrounding tissue into the provisional matrix. bFGF stimulates the chemotaxis
of skin fibroblasts and granulation tissue fibroblasts in vitro (Buckley-Sturrock,
Woodward et al. 1989). bFGF has been shown to promote the migration of fibroblasts
through the phosphoinositide 3-kinase (PI3-Kinase)-Rac1-JNK pathway (Kanazawa,
Fujiwara et al. 2010). Transfection of NIH 3T3 fibroblasts with bFGF cDNA increased
migration and the addition of antibodies to bFGF inhibited migration, indicating that
bFGF plays a role in fibroblast migration and the effect is mediated in part through
autocrine bFGF secreted into the extracellular space (Mignatti, Morimoto et al. 1991,
Mignatti, Morimoto et al. 1992).

1.5.4

Mitogenic Effects

Fibroblast proliferation is essential during wound healing. Expression of bFGF cDNA in
mouse BALB/c 3T3 fibroblast mouse cells induced the growth of these cells compared to
non-transfected parental cells (Sasada, Kurokawa et al. 1988). bFGF is mitogenic for
skin fibroblasts and granulation tissue fibroblasts (Buckley-Sturrock, Woodward et al.
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1989). In addition, during periodontal wound healing a new functional epithelial seal
must form, and bFGF has been shown to stimulate the proliferation of gingival epithelial
cells, with the effect being moderately attenuated in the presence of serum (Takayama,
Yoshida et al. 2002).

1.5.5

Role of bFGF in Wound Healing

The importance of bFGF in wound healing is evident from studies using bFGF knockout
mice. Although the mice are viable, survive to adulthood and have no visible
abnormalities, when injured, these mice show a significant decrease in the rate of skin
healing (Ortega, Ittmann et al. 1998). Furthermore, the addition of bFGF to wounds
accelerates the rate of wound healing (Ribatti, Nico et al. 1999, Akita, Akino et al. 2008,
Tan, Xiao et al. 2008). Topical application of bFGF to experimentally created rat palatal
wounds was found to accelerate the formation of granulation tissue and
reepithelialization of the wound with an observed increase in basal epithelial cell
proliferation (Oda, Kagami et al. 2004).
bFGF is known to have effects at several different stages of wound healing. During the
inflammatory phase of wound healing, monocytes secrete growth factors to resolve the
wound and stimulate the formation of granulation tissue (Wahl, Wong et al. 1989).
Monocytes in the wound area are converted to macrophages and secrete several growth
factors including platelet derived growth factor, interleukin-1, tumour necrosis factor and
bFGF which act upon fibroblasts in the healing wound (Mahdavian Delavary, van der
Veer et al. 2011). Angiogenesis is a key event in wound repair and involves the
migration of endothelial cells from existing vasculature into the wound space. bFGF
primes endothelial cells for angiogenesis and alters the expression of integrins allowing
for migration into the wound bed (Klein, Giancottiti et al. 1993). The final stage of
wound repair is characterized by remodeling of the collagen matrix to produce a
functional connective tissue. Apoptosis of myofibroblasts is required for wound
resolution and bFGF has been shown to play a role in the apoptosis of myofibroblasts in
vitro (Funato, Moriyama et al. 1997) and in vivo during palatal wound healing (Funato,
Moriyama et al. 1999). bFGF downregulates collagen synthesis in normal skin
fibroblasts and stimulates the production of the collagen digesting enzyme, collagenase,
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in normal skin fibroblasts and granulation tissue fibroblasts (Buckley-Sturrock,
Woodward et al. 1989, Tan, Rouda et al. 1993).

Hypothesis and Objectives

1.6
1.6.1

Rationale

Biomaterial scaffold membranes hold great promise for use in GTR applications in that
they can be fabricated to mimic the fibrous ECM architecture of the connective tissue and
can be used to deliver growth factors, thus acting as a mechanically stable substitute
ECM during tissue repair. Electrospun PCL scaffolds loaded with bFGF microspheres
have been shown to enhance dermal fibroblast infiltration in vitro and enhance
angiogenesis in cutaneous wounds in vivo (Guo, Elliott et al. 2012). Since dermal
fibroblasts differ from gingival fibroblasts (Palaiologou, Yukna et al. 2001) and the
periodontium represents a unique wound healing environment, it is of significance to
study the response of gingival fibroblasts to bFGF loaded electrospun PCL scaffolds and
subsequently assess the ability of the scaffolds to promote gingival wound healing.

1.6.2

Overall Hypothesis

We hypothesize that the sustained release of bFGF from PLGA microspheres loaded on
an electrospun PCL scaffold with a pore diameter of 17.1 ± 8.3 µm will serve as a matrix
for gingival fibroblast ingrowth and promote gingival wound healing.

1.6.3

Specific Hypothesis and Objectives

Release of bFGF from PCL electrospun scaffolds will increase the proliferation, matrix
deposition and infiltration of gingival fibroblasts while maintaining a barrier to oral
epithelial cells. bFGF release from PCL electrospun scaffolds will accelerate gingival
wound healing. To test this hypothesis the following objectives were formulated:
1. To characterize the influence of PCL electrospun fibrous scaffolds loaded with
bFGF microspheres on human gingival fibroblasts in vitro and gingival tissue ex
vivo.
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a. Assess human gingival fibroblast attachment, proliferation and matrix
synthesis and deposition.
b. Assess cell infiltration from gingival tissue explants.
2. To assess the influence of PCL electrospun fibrous scaffolds loaded with bFGF
microspheres on the rate of wound healing following gingivectomy in a rat model.
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Chapter 2

2

Influence of Electrospun Polycaprolactone Fibrous
Scaffolds Loaded with Basic Fibroblast Growth Factor
Microspheres on Gingival Augmentation
2.1

Introduction

Periodontal disease affect the tissues that support the teeth (AAP 2001). Collectively
referred to as the periodontium, these tissues are comprised of the alveolar bone,
cementum, periodontal ligament (PDL) and the gingiva. Periodontal disease ranges in
severity from mild inflammation of the gingiva, termed gingivitis, to more aggressive
bacterial-induced inflammatory conditions. Periodontitis is the more severe periodontal
pathology in which the chronic presence of bacteria induces a host immune response
resulting in the loss of connective tissue attachment to the tooth; destruction of the
gingiva, PDL, and cementum followed by resorption of the alveolar bone which can
result in tooth mobility and loss (Pihlstrom, Michalowicz et al. 2005). Periodontitis is
one of the most common connective tissue disorders worldwide and affects 47% of the
U.S. adult population (Eke, Dye et al. 2012). In addition to its high prevalence, the main
concern with periodontitis is the limited capacity for repair of the periodontium, and
without surgical intervention, the disease is irreversible (Bartold, McCulloch et al. 2000).
Conventional interventions remove the causative bacterial agents and serve to slow the
progression of periodontitis, but do not facilitate appreciable or predictable regeneration
of the lost periodontal structures. Such interventions often result in tissue shrinkage and
fibrosis leaving the patient with gingival recession (Wikesjo and Selvi 1999, Hughes,
Ghuman et al. 2010). Guided tissue regeneration is a surgical intervention for
periodontitis wherein a barrier membrane is placed under the gingival connective tissue
and against the tooth to function as a space making barrier excluding the gingival tissue
from the regenerating periodontal defect, thus creating a compartment into which the
PDL and alveolar bone can repopulate (Aurer and Jorgic-Srdjak 2005). Resorbable
membranes for GTR have been developed as they eliminate the need for a second surgery
for membrane removal. However, the membranes employed are not optimal exhibiting

43

variable clinical improvement, therefore significant improvements can be made to their
design (Bartold, McCulloch et al. 2000). As current membranes are cell occlusive,
gingival connective tissue is isolated from the periodontal pocket cutting off a potential
supply of stem and progenitor cells from the healing defect along with the rich vascular
supply (Schroeder and Listgarten 1997, Fournier, Larjava et al. 2013).
With increasing knowledge of wound healing and advances in technology in the field of
materials science, biomaterial scaffold-membranes can be fabricated which play a more
active role in periodontal wound healing. PCL is a bioresorbable, aliphatic polyester (Mw
80 000) with a relatively long degradation time (Dong, Liau et al. 2009). PCL is an ideal
biomaterial for use in scaffold membrane applications due to its low cost, ease of
fabrication, biocompatibility, and has been approved by the U.S. Food and Drug
Administration for medical applications (Dong, Liau et al. 2009). Several techniques
exist for fabrication of fibrous biomaterial scaffolds including phase separation (Nam and
Park 1999), self-assembly (Zhang 2003) and electrospinning (Pham, Sharma et al. 2006).
Electrospinning is advantageous in that the set-up is convenient and cost effective, and
unlike the other methods, is easily scalable (Dong, Liau et al. 2009). Electrospinning
produces scaffolds which are ideal for tissue regeneration applications due to the ability
to customize fiber diameter and orientation, the high surface area to volume ratio,
interconnected porosity, and the ability to incorporate growth factors, thus closely
mimicking the structure of the natural ECM. Moreover, by tailoring the pore size
between the fibers in the scaffold, cell migration into and through the scaffold can be
facilitated (Lowery, Datta et al. 2010).
In addition to alterations in the structure of the scaffold, incorporation of growth factors
into the scaffold increases their biocompatibility and functionality. The heparin-binding
protein bFGF is a potent mitogen capable of stimulating fibroblast proliferation in a dosedependent manner (Gospodarowicz 1974, Nugent and Iozzo 2000). bFGF is also a potent
stimulator of angiogenesis in vivo and stimulates the migration and proliferation of
endothelial cells in vitro (Gospodarowicz, Ferrara et al. 1987, Murakami and Simons
2008). bFGF accelerates the healing of oral wounds and stimulates periodontal
regeneration in animal models (Murakami, Takayama et al. 1999, Murakami, Takayama

44

et al. 2003, Oda, Kagami et al. 2004, Ayvazyan, Morimoto et al. 2011). These
observations were further investigated in clinical trials that found that topical applications
of bFGF were able to regenerate periodontal tissue in patients with periodontitis
(Kitamura, Nakashima et al. 2008, Kitamura, Akamatsu et al. 2011). While bFGF has
shown promise clinically, topical application is not an optimal method of delivery due to
the requirement for a large dose to be administrated in an effort to compensate for the
rapid degradation and inactivation of growth factors delivered this way. Attempts at
sustained release of bFGF from scaffolds has been investigated using
chitosan/hydroxyapatite freeze dried scaffolds and collagen/gelatin scaffolds (Tigli,
Akman et al. 2009, Akman, Tigli et al. 2010). However these scaffolds either have a
fairly rapid release of bFGF or rapid degradation of the scaffold itself. We have
previously developed a PCL electrospun scaffold loaded with microspheres of poly
(lactide-co-glycolide) containing a core of bFGF stabilized with heparin, which supported
the migration of dermal fibroblasts into the scaffold in vitro and promoted angiogenesis
following subcutaneous implantation (Guo, Elliott et al. 2012).
The aim of this study was to investigate the in vitro biocompatibility of human gingival
fibroblasts on PCL electrospun scaffolds loaded with bFGF microspheres and the
efficacy of the scaffolds in the early stages of gingival wound healing in vivo. The
attachment, proliferation, infiltration/migration, and matrix synthesis of human gingival
fibroblasts on scaffolds loaded with bFGF microspheres was evaluated and compared to
scaffolds without bFGF. We then assessed the influence of PCL scaffolds loaded with
bFGF microspheres on reepithelialization and connective tissue formation following
gingivectomy in a rat model.

2.2
2.2.1

Materials and Methods
Cell Cultures and Tissue Explants

Human gingival fibroblasts (hGFs) were isolated and cultured from clinically healthy
gingival tissue received from patients undergoing routine dental surgery at Western
University Schulich School of Medicine and Dentistry Oral Surgery Clinic with informed
patient consent. hGFs were cultured from both male and female patients aged 15 to 79
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years of age. Excised gingival tissue was isolated in Dulbecco’s Modified Eagle
Medium (DMEM) (Gibco, Cat # 11995-065, Carlsbad, CA, USA) supplemented with
10% fetal bovine serum (FBS) (Gibco, Cat # 12483-020) and antibiotic-antimicotic (AA)
(100 U/mL penicillin, 100 µg/mL streptomycin and 0.25 µg/mL amphotericin B; Gibco,
Cat # 15240-062) at 4°C. Tissue was rinsed in phosphate buffered saline (PBS), pH 7.4
(Gibco, Cat # 10010-023) and the epithelium was mechanically separated from
underlying connective tissue using a No. 15 scalpel blade. Connective tissue was minced
and cultured on polystyrene tissue culture treated plates (Corning, Tewksbury, MA,
USA) in DMEM supplemented with 10% FBS and AA (culture medium) at 37°C in a
humidified atmosphere of 95% air and 5% CO2. Once wells became confluent, gingival
fibroblasts were dissociated from the growth surface using 0.05% Trypsin-EDTA (Gibco,
Cat # 25300-054) and passaged 1:3 in 75 cm2 polystyrene tissue culture treated flasks
(Corning). For use in cell experiments, hGFs were grown to 80-90% confluence,
dissociated from the growth surface, and cell number was determined using a Multisizer
3 Coulter Counter (Beckman Coulter, Mississauga, ON, Canada). Cells were used
between passages 2 and 8 and in some instances frozen in liquid nitrogen prior to use.
Experiments were carried out in culture media supplemented with 50 µg/mL ascorbic
acid (experimental media) at 37°C in a humidified atmosphere of 95% air and 5% CO2.
Gingival tissue explants (GTEs) were used directly for certain experiments. The tissue
was cut on five faces, leaving the surface epithelium undisturbed, using a No. 15 scalpel
blade into 2 mm3 blocks composed of connective tissue and attached epithelium as
illustrated in Figure 2.1. GTEs were used immediately for experiments.
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Figure 2.1 – Gingival tissue explant as an ex vivo experimental system.
Gingival tissue was cut into cubes along five faces, with the exception of the epithelial
surface, into 2 mm3 blocks to be used for experiments.
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2.2.2

Electrospun Fibrous Polycaprolactone Scaffolds Loaded with
bFGF

Scaffolds were fabricated in, and obtained from the laboratory of Dr. Jianjun Guan (The
Ohio State University, Columbus, OH, USA). Briefly, scaffolds were created using a
two-stream electrospinning and electrospraying apparatus. Scaffolds were created by
electrospinning a positively charged solution of PCL onto a negatively charged rotating
collecting mandrel to form a fibrous construct. Simultaneously during fabrication, a
second positively charged stream was used to electrospray microspheres with a core-shell
structure consisting of a basic fibroblast growth factor core and a shell of poly (lactideco-glycolide). The result was a fibrous construct composed of PCL fibers with uniform
distribution of PLGA microspheres with a bFGF core throughout. The bFGF solution
had a concentration of 150 µg/mL and contained 0.05 wt % heparin to protect the bFGF
from denaturation. The rate at which the bFGF solution was injected during the
fabrication process was altered to produce scaffolds with different amounts of bFGF. An
injection rate of 0.1 mL/hour and 0.7 mL/hour both with constant 1 mL/hour injection
rate of PLGA created scaffolds with low bFGF and high bFGF loading, respectively. The
constant injection rate of PLGA in low and high bFGF loaded scaffolds maintained a
uniform density and distribution of the microspheres within the scaffold (Guo, Elliott et
al. 2012). As a control, a scaffold without bFGF loading was also tested.
The scaffolds were characterized (Guo, Elliott et al. 2012) and found to have a sustained
bFGF release over a 28 day period in PBS at 37°C. Approximately 50 mg pieces of
scaffold released 35 ng and 20 ng for the high bFGF and low bFGF loading, respectively,
over the 28 day period. The kinetics of bFGF release were found to occur in two stages
with a relatively fast and nonlinear release in the first seven days (25 ng for the high
bFGF scaffold, and 15 ng for the low bFGF scaffold) followed by the remainder being
released relatively slower with a linear release profile in the days following.
Prior to use in experiments, the scaffolds were cut into appropriate sizes and sterilized in
70% ethanol for 20 minutes at room temperature (RT) and washed three times for 5
minutes in sterile water followed by one wash in experimental media for in vitro
experiments and an additional wash in sterile water for in vivo experiments.
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2.2.3

Human Gingival Fibroblast Attachment

Scaffolds were cut into 6 mm disks using a disposable biopsy punch (Integra Miltex,
York, PA, USA) and sterilized. Scaffolds were placed into 96 well plates (Corning) and
hGFs were seeded onto the scaffold surface at a density of 3.5 x 104 cells/cm2. Cells
were cultured on the scaffolds for 1, 2, 4 or 24 hours at which time they were gently
rinsed once with PBS to remove non-adherent cells and fixed using 4%
paraformaldehyde (PFA) in PBS at RT for 10 minutes. Cell seeded constructs were
rinsed three times with PBS and dehydrated through a graded series of ethanol (50%,
70% and 90%) followed by three changes of anhydrous ethanol for 10 minutes per step.
To preserve cell morphology, cell seeded constructs were immersed in
hexamethyldisilazane (HMDS) (Sigma-Aldrich, St. Louis, MO, USA) for 15 minutes, air
dried for 30 minutes and stored in a desiccator overnight. Samples were coated with 5
nm osmium metal using a Filgen OPC80T Osmium Plasma Coater (Filgen, Midori-ku,
Nagoya, Japan) and visualized by scanning electron microscopy (SEM) using a Hitachi
3400-N Variable Pressure Scanning Electron Microscope (Hitachi, Mississauga, ON,
Canada) to acquire images using an acceleration voltage of 2.00 kV. Photoshop 7.0
software (Adobe Systems Incorporated, San Jose, CA, USA) was used to pseudocolour
attached cells.

2.2.4

Gingival Fibroblast Cell Number

Scaffolds seeded with hGFs at a density of 7 x 103 cells/cm2 in 96-well plates were
cultured for 1, 5 or 9 days with the addition of 50 µL experimental media every 2 days.
Cell number on the scaffolds at each time point was determined using a CyQUANT®
Cell Proliferation Assay kit (Molecular Probes, Carlsbad, CA, USA) (Jones, Gray et al.
2001). At each experimental time point the media was gently removed and scaffolds
were rinsed in PBS to remove non-adherent cells and residual media. Scaffolds were
transferred to a 500 µL microcentrifuge tube (Port City Diagnostics, Wilmington, NC,
USA) and stored at -80°C until the end of the experimental culture period. Once all
experimental time points were frozen, the assay was conducted according to
manufacturer’s specifications. Briefly, scaffolds were thawed and incubated with 250 µL
CyQUANT® GR working solution for 5 minutes at RT with vigorous vortexing. 200 µL
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of the incubated working solution was transferred to a 96-well microplate. A standard
curve was created from a 1 x 106 hGF cell pellet frozen at the beginning of the
experiment. Sample fluorescence was measured using a Safire2 microplate reader
(Tecan, Männedorf, Switzerland) at an excitation wavelength of 480 nm and an emission
wavelength of 520 nm.

2.2.5

Ex-Vivo Explant Cultures

Gingival tissue explant blocks were placed on sterilized 6 mm scaffold disks in 3.5 cm
diameter polystyrene dishes (Corning), oriented such that the surface epithelium was not
in contact with the scaffold surface, and cultured submerged in experimental media for 3
weeks. Half of the media was removed and replaced every two days for the duration of
the experiment taking care not to disrupt explant tissue. Explant tissue and scaffolds
were fixed in 10% neutral buffered formalin (Sigma-Aldrich) at 4°C overnight. Samples
were prepared for SEM (as described above) and for frozen sections.
Samples to be used for frozen sections were prepared for embedding by rinsing in PBS
once for 15 minutes, 4% sucrose (Sigma-Aldrich) in PBS three times for 15 minutes and
sinking in 30% sucrose in PBS at 4°C overnight. The following day, samples were rinsed
in 30% sucrose in water three times for 15 minutes and sunk in a 50:50 mixture of 30%
sucrose in water and VWR Premium Frozen Section Compound (VWR International,
Radnor, PA, USA) for 1 hour at RT. For embedding, the samples were sunk in VWR
Premium Frozen Section Compound and placed in an embedding mold such that sections
along the face of the block cut along the length of the scaffold. Samples were frozen in
liquid nitrogen until almost completely frozen then left on dry ice for 20 minutes to
complete freezing. Samples were stored in sealed containers at -20°C for short term
storage.
Frozen blocks were sectioned at 10 µm using a Leica CM3050 S cryostat (Leica,
Wetzlar, Germany). Sections containing explanted tissue were mounted on Superfrost
Plus slides (Fisher Scientific, Waltham, MA, USA), air dried at RT and stored at -20°C
until ready to be stained.
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Three sections per sample, at least 50 µm apart, were stained for vimentin to visualize the
location of cells of mesenchymal origin. Additional sections were stained for keratin 17
to localize epithelial cells. Sections were rehydrated in PBS for 30 minutes at RT.
Endogenous peroxidase activity was quenched with 3% hydrogen peroxide (H2O2) in
methanol for 5 minutes. Non-specific antibody binding was blocked using 10% horse
serum for 30 minutes at RT prior to application of the primary antibody against vimentin
(clone EPR3776, Abcam, Cambridge, England, UK) at a 1:400 dilution or keratin 17
(A2175, NeoBiolab, Cambridge, MA,USA) at a dilution of 1:100. Sections were
incubated with the primary antibody at 4°C overnight. Sections were rinsed three times
in PBS to remove unbound antibodies and sections were incubated for 30 minutes at RT
with ImmPRESS HRP Anti-Rabbit Ig (Peroxidase) reagent (Vector Laboratories,
Burlingame, CA, USA). Unbound reagent was rinsed from the section using PBS and 3,
3ʹ-diaminobenzidine (DAB) peroxidase substrate (Vector Laboratories) was used to
develop the reagent according to manufacturer’s instructions. Colour development was
stopped by rinsing sections with water. Negative control sections were made by omitting
the primary antibody. All sections were counterstained using Harris Modified
Hematoxylin Solution (Sigma-Aldrich). Stained sections were imaged using an Axio
Imager M1 microscope (Zeiss, Oberkochen, Germany) and AxioImager software.
ImageJ 1.48v software (National Institutes of Health, Bethesda, MD, USA) was used to
calculate the distance of each vimentin-positive cell from the surface of the scaffold.

2.2.6

Immunocytochemical Analysis

Scaffolds seeded with hGFs at a density of 8.8 x 104 cells/cm2 in 96-well plates were
cultured for 3 or 7 days with the addition of 50 µL experimental media every 2 days.
Cells were fixed with 4% PFA in PBS for 10 minutes, rinsed three times with PBS and
blocked with 1% bovine serum albumin (BSA) in PBS for 30 minutes. Scaffolds were
incubated with primary antibodies diluted 1:100 in 1% BSA in PBS against the
extracellular matrix (ECM) proteins biglycan (ab54855, Abcam), decorin (ab54728,
Abcam) and fibronectin (EP5, Santa Cruz Biotechnology, Dallas, TX, USA) at 4°C
overnight. Scaffolds were gently washed with PBS five times for 10 minutes each and
blocked with 1% BSA in PBS for 5 minutes. Scaffolds were then incubated, protected
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from light, for 90 minutes at RT with Alexa Fluor 488 Goat Anti-Mouse IgG antibody
(Molecular Probes) at a 1:200 dilution. Following incubation, the scaffolds were washed
five times for 10 minutes in PBS and mounted on glass coverslips using Vectashield
Mounting Medium (Vector Laboratories) with 4ʹ, 6-diamidino-2-phenylindole (DAPI).
Samples were imaged using an Axio Observer.Z1 fluorescence microscope (Zeiss).
Axiovision Software Release 4.8.0.0 was used to capture images. Negative control
samples were prepared with the omission of the primary antibody and used to set the
threshold for fluorescence detection (Appendix D, F, H). Due to the thickness of the
samples being imaged, z-stacks were acquired and extended depth of focus was
employed using the Axiovision software.

2.2.7

Human Gingival Fibroblast Extracellular Matrix Gene
Expression

Scaffolds seeded with hGFs at a density of 2 x 105 cells/cm2 in 96-well plates were
cultured for 3 or 7 days with the addition of 50 µL experimental media every 2 days.
Total RNA was isolated using TRIzol Reagent (Ambion, Carlsbad, CA, USA). Isolated
RNA was purified using a PureLink RNA Mini Kit (Ambion) according to the
manufacturer’s directions. Quantitative real-time reverse transcription polymerase chain
reaction (RT-qPCR) was used to determine the gene expression level of biglycan (BGN,
Hs00959141_g1) and fibronectin (FN1, Hs01549958_m1). 15 µL reactions containing:
3-15 ng RNA; qScript XLT One-Step RT-qPCR ToughMIX master mix reagent (Quanta
Biosciences, Gaithersburg, MD, USA); TaqMan Gene Expression Assay (Life
Technologies, Carlsbad, CA) containing PCR primers for FN1, BGN or 18S and a FAM
dye labelled TaqMan probe; and RNase free water. Thermal cycling conditions for
amplification were 30 minutes at 48°C (reverse transcription), 10 minutes at 95°C
(polymerase activation) followed by 40 cycles of each 15 seconds at 95°C and 1 minute
at 60°C (melt and anneal/extend, respectively). A dilution series was created from
pooled RNA samples to test the efficiency of each target gene expression assay primer
and probe set compared to the reference gene, 18S. Gene expression levels of FN1 and
BGN were normalized to the levels of endogenous 18S rRNA. Data are presented as a
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relative quantification of gene expression of samples relative to the PCL alone scaffold at
day 3 using the 2-ΔΔCT method (Livak and Schmittgen 2001).

2.2.8

Rat Gingivectomy Model

Fifteen adult female Wistar rats aged 8 to 20 weeks weighing between 160 and 370 g
were used in experiments (a generous gift from the lab of Dr. Stephen Sims, Western
University, London, ON, Canada). All animal procedures were approved by the
University Council on Animal Care of Western University. Gingivectomy was
performed on the maxiallary palatal gingiva or mandibular buccal gingiva by one
operator (Figure 2.2). Animals were anesthetized by intraperitoneal injection of
Ketamine-Xylazine (75 mg/kg Ketamine and 10 mg/kg Xylazine). A small, round dental
instrument was used to disrupt the junctional epithelium and a No. 15 scalpel blade was
used to raise a full-thickness 900 µm wide gingival flap along the first, second and third
molars. The No. 15 scalpel blade was then used to excise the soft connective tissue flap
and a small dental blade was used to thoroughly remove any remaining soft connective
tissue on the tooth or bone. To maintain hemostasis, cotton swabs were held over the
wound with slight pressure. Wounds received either PCL alone, low bFGF or high bFGF
scaffolds or no scaffold (empty defect) as a control (n = 6 wounds receiving low bFGF
and high bFGF scaffolds and n = 9 wounds receiving PCL alone scaffold or an empty
defect). Two sterilized scaffold strips 1 mm x 3 mm in size were placed into the
experimental surgical wounds on top of one another to create a double layer and held in
place with a small amount of Vetbond tissue adhesive (Figure 2.2). A subset of animals
(n =3) with empty defects and PCL alone scaffolds were euthanized by carbon dioxide
inhalation immediately following surgery completion to serve as a day 0 baseline.
Remaining animals received 0.5 mg/kg Buprenorphine by subcutaneous injection twice
daily for 48 hours post-surgery as an analgesic. Animals were maintained on a standard
lab chow powdered food diet and were allowed food and water ad libitum for the
duration of the experiment.
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Figure 2.2 - Gingivectomy in a rat model and scaffold placement.
Gingivectomy was performed in adult female Wistar rats. Soft gingival tissue was
removed and two layers of sterilized scaffolds were placed in the defect. A) Macroscopic
view of scaffold placement in the gingival wound. White arrow – Molars, Black arrow –
Scaffold placement. B) Uninjured gingival tissue. B – Alveolar bone, G – Gingiva, D –
Dentin, E – Enamel space. Dashed red line demarcates approximate location of wound
edge to be created following gingivectomy. C) Immediately following gingivectomy in
an empty defect. Dashed red line indicates wound edge. D) Immediately following
gingivectomy in a PCL alone treated defect. Dashed red line indicates wound edge.
Black arrow indicates the scaffold.
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Animals were euthanized 3 (n = 6) or 7 (n = 6) days post-gingivectomy by carbon
dioxide inhalation. Heads were fixed in 10% neutral buffered formalin (Sigma)
overnight at 4°C. Jaws were excised and tissues were subsequently decalcified at 4°C for
48 hours in two changes of Cal-Ex Decalcifier (Fisher Chemical, Waltham, MA, USA).
Molars were processed en bloc for frozen sections or by routine paraffin embedding.
Serial 5 µm sections were taken in the mesio-distal plane encompassing the second
molar.
Sections were rehydrated and stained with hematoxylin (Sigma) and eosin (alcoholic;
Leica) (H&E), Van Gieson, and Masson’s Trichrome. Images were taken with a Leica
DM100 light microscope (Leica). Histomorphometric analysis of H&E stained sections
of the wounds was completed using ImageJ 1.48v software (National Institutes of Health,
USA) to measure the epithelial migration distance, the area of regenerated gingival
connective tissue, and biologic width; as indicated by connective tissue attachment and
junctional epithelium length (Khuller and Sharma 2009) (Figure 2.3). Connective tissue
attachment was measured from the crest of the alveolar bone to the apical most epithelial
attachment. Junctional epithelium length was measured from the most apical epithelial
attachment to the bottom of the gingival sulcus. Biologic width was the combined
measurement of connective tissue attachment and junctional epithelium length (Figure
2.3).
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Figure 2.3 - Biologic width.
Measurements of biologic width were made on H&E stained sections of rat gingival
wounds. Measurement parameters are indicated on uninjured tissue. Horizontal green
lines demarcate boundaries between which measurements are made, vertical lines
indicate distances measured. Biologic width (BW) is the combined measurement of
connective tissue attachment (CTA) and junctional epithelium length (JE). Sulcular
depth (SD) is indicated, however does not contribute to the biologic width measurement.
Red dashed line demarcates the approximate location of the wound edge which would be
created following gingivectomy.
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Immunohistochemical staining for arginase-1 (V-20:sc-18354, Santa Cruz), alpha smooth
muscle actin (α-SMA) (clone 1A4, A5228, Sigma-Aldrich) and proliferating cell nuclear
antigen (PCNA) (ab2426, Abcam) was performed to visualize M2 phenotype
macrophages, myofibroblasts (α-SMA positive cells not associated with blood vessels)
and proliferating cells in the wound area, respectively. Sections were rehydrated,
permeabilized using 0.1% Triton X-100 in PBS for 5 minutes at RT, rinsed in PBS and
blocked using 10% horse serum. Sections were incubated with primary antibodies
against arginase-1, α-SMA and PCNA diluted 1:100 in 10% horse serum for 1 hour at
room temperature. Sections were rinsed in PBS and incubated, protected from light, for 1
hour at RT with an appropriate Cy5 conjugated secondary antibody. Sections were rinsed
with PBS to remove unbound antibody and mounted using Vectashield Mounting
Medium with DAPI. Sections were imaged using an AxioImager.M2m (Zeiss) with Zen
software (Zeiss). Negative control sections were created in which the primary antibody
was omitted and used to set the threshold level for fluorescence detection (Appendix L).
ImageJ 1.48v software (National Institutes of Health, USA) was used to quantify the
number of myofibroblasts and proliferating cells in the wound area.

2.2.9

Statistical Analysis

Data are presented as mean ± SD of triplicate experiments. Statistical analysis was
performed using GraphPad Prism software version 5.01 for Windows (GraphPad
Software, San Diego, CA, USA). Data were analyzed using a two-way ANOVA with
Bonferroni’s post-test, with the exception of biologic width calculations which were
analyzed using a one-way ANOVA with Kuskal-Wallis post-test. A p-value of less than
0.05 was considered statistically significant.
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2.3
2.3.1

Results
Attachment and Morphology of hGFs on PCL Electrospun
Scaffolds Loaded With bFGF

SEM was used to visualize hGF attachment, spreading and morphological changes on
scaffolds with and without bFGF loaded microspheres. hGFs attached within 1 h and
began spreading, with extension of cellular processes along the scaffold fibers evident on
all scaffold types (Figure 2.4A). Cells attached to and spanned across multiple fibers
within the scaffolds, but remained on the surface of the scaffolds. By 2 h both cell
processes and cell bodies began penetrating the scaffolds, and were evident under the top
fiber layer (Figure 2.4B). Cell morphology was observed to be influenced by the
underlying fiber architecture of the scaffolds. By 24 h cells on scaffolds containing
bFGF were seen to make contact with the microspheres (Figure 2.4B).

2.3.2

bFGF Loaded PCL Electrospun Scaffolds Increase hGF Cell
Number

Increase in hGF cell number on each scaffold was assessed at 1, 5, or 9 days postseeding. All three scaffolds supported an increase in cell number as DNA content on
each of the three scaffolds increased with time (Figure 2.5). At 5 days post-seeding, the
low bFGF loaded scaffold significantly increased cell number compared to the PCL alone
scaffold and the high bFGF loaded scaffold for one of the patient cells tested. At 9 days
post-seeding, the scaffold with low bFGF loading significantly increased cell number
compared to the PCL alone scaffold for two of the patient cells tested while the hGFs
from the third patient showed a significantly larger cell number on the scaffold with high
bFGF loading (Figure 2.5).
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Figure 2.4 - hGF attachment and morphology.
A) SEM micrographs show hGFs (pseudo-coloured blue) attached to and spread along
the scaffold fibers on PCL electrospun scaffolds both with and without bFGF
microspheres at 1 hour. The scaffold architecture influenced cell morphology. Red
arrows indicate cell contact with bFGF loaded microspheres. Scale bar = 50 µm B)
Higher magnification SEM micrographs showing cells contacting the fibers of the
scaffold with both large and small cell processes in as little as 1 hour. By 2 hours, cell
processes were seen extending down into the scaffold and cell bodies were seen below
the superficial fibers. Red arrows indicate cell contact with bFGF loaded microspheres.
Scale bar = 30 µm (1 and 24 hours), Scale bar = 20 µm (2 and 4 hours). Images are
representative of a single experiment.
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Figure 2.5 - hGF cell number.
hGFs were seeded onto all three scaffold types and cultured for 1, 5 or 9 days. Cell
number at each time point was determined by quantification of DNA using a
CyQUANT® assay. Data are presented as mean ± SD of the fold change in cell number
relative to the PCL alone scaffold at day 1. Data are presented as individual donor
patient cells with three experimental replicates. Two-way ANOVA with Bonferroni’s
post-test was conducted to compare means, *p<0.05, **p<0.01, ***p<0.001.
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2.3.3

Interaction of Gingival Explant Tissue with PCL Electrospun
Scaffolds Loaded with bFGF

In the next experiments, gingival tissue explants were cultured on the surface of PCL
electrospun scaffolds with and without bFGF microspheres for three weeks. Cells grew
out from the explants on all scaffold surfaces and appeared as cell sheets on the top of the
scaffold fibers. Sheets on the scaffolds containing bFGF appeared more confluent
(Figure 2.6B, C), whereas on the PCL alone scaffold (Figure 2.6A) cells are more
sparsely distributed on the scaffold surface.
To further assess cell growth and migration on and into the scaffolds, sections of gingival
tissue explants cultured on the scaffolds for three weeks were cut and cell type assessed
using vimentin immunoreactivity, which allows separation of cells of mesenchymal
origin and epithelial cells. Vimentin-positive cells had migrated into the scaffolds with
and without bFGF from the explants (Figure 2.7A). Scaffolds with high bFGF loading
had significantly more cells than scaffolds with low bFGF loading or with no bFGF
loading for at least one depth from the scaffold surface in all three patient tissues
(p<0.05) (Figure 2.7B). Two of the three patient tissues showed significantly more cells
in the high bFGF scaffold as compared to the scaffold without bFGF for several depths
from the scaffold surface (p<0.05) while the third patient tissue showed this trend,
however it was not statistically significant (Figure 2.7B).
In some instances the epithelium from the explanted gingival tissue migrated along the
exterior surface of the tissue at the interface between the tissue and the scaffold. The
epithelial cell phenotype was assessed by non-reactivity to vimentin and positive labeling
for keratin 17 (Figure 2.8). In both instances, the epithelial cells showed minimal
migration into the interior of the scaffold, staying on the surface of both the PCL alone
and high bFGF loaded scaffold. The epithelial sheet on the high bFGF loaded scaffold
qualitatively was thicker than the epithelial sheet migrating along the PCL alone scaffold.
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Figure 2.6 - SEM of gingival tissue explants.
Gingival tissue explants consisting of gingival connective tissue and attached epithelium
were cultured on the surface of PCL electrospun scaffolds with and without bFGF
loading for 3 weeks. SEM micrographs show cells (pseudo-coloured blue) on the surface
of the scaffold adjacent to the gingival tissue explants (pseudo-coloured purple). A) PCL
alone scaffold. B) Low bFGF scaffold. C) High bFGF scaffold. Images are
representative of a single experiment using tissue from one patient. Scale bars = 500 µm.
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Figure 2.7 - Population of the PCL electrospun scaffolds by cells from gingival tissue
explants.
A) Vimentin-positive cells were observed within the interior of the scaffolds both with
and without bFGF. Red dashed lines delineate the PCL scaffolds. Red arrows indicate
vimentin-positive cells within the scaffolds. Images are representative of three patient
tissues with three experimental replicates. Scale bars = 200 µm. B) The distance each
vimentin-positive cell was located from the surface of the scaffold was measured for
three separate patient tissues. Scaffolds with high bFGF loading had significantly more
cells than scaffolds with no bFGF or low bFGF for at least one depth from the scaffold
surface in all three patient tissues. *p<0.05, **p<0.01, ***p<0.001. Two-way ANOVA
with Bonferroni post-test was conducted to compare means. Data presented for each
patient as mean ± SD of three sections from three experimental replicates.
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Figure 2.8 - PCL electrospun scaffolds as a barrier to oral epithelial cells.
When epithelial cells from the explant tissue migrated to the interface between the tissue
and the scaffold, epithelial cells migrated along the surface of the scaffold with minimal
penetration into the scaffolds. Vimentin staining, excluding epithelial cells, and keratin
17 staining, a marker of epithelial cells, showed minimal scaffold penetration by
epithelial cells both in the presence and absence of bFGF microspheres. Red dashed lines
delineate the PCL scaffold.
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2.3.4

hGF ECM Secretion is Modulated by bFGF on PCL
Electrospun Scaffolds

We next investigated whether addition of bFGF to the scaffolds influenced secretion and
deposition of fibronectin, biglycan, and decorin by hGF cells seeded onto the scaffolds.
Localization of all three ECM proteins on the surface of each scaffold was initially
visualized with fluorescent microscopy at low magnification (Appendix C, E, G) to
qualitatively assess deposition across a large scaffold area. Higher magnification images
were taken to assess deposition on the surface of the scaffold associated with the cells.
Fibronectin deposition was evident on all scaffold types after 3 days (Figure 2.9). By 7
days of culture, fibronectin deposition on the surface of the scaffold remained evident on
all three of the scaffold types.
Biglycan immunoreactivity was observed on the surface of the scaffolds after 3 days of
culture although remained intracellular with little evidence of secretion into the ECM
(Figure 2.10). Biglycan appeared most prominent on the PCL alone scaffold and was
diminished in the presence of bFGF release. After 7 days of culture, biglycan
immunoreactivity remained intracellular.
At 3 days post-seeding, decorin immunoreactivity is observed on all of the scaffold types
(Figure 2.11). Decorin immunoreactivity appeared to be most prominent in the presence
of bFGF and was mainly associated with the cells. After 7 days of culture, decorin
remained associated with the cells.
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Figure 2.9 - Fibronectin immunoreactivity on the scaffold surface.
The secretion and deposition of the structural ECM protein fibronectin by hGFs cultured
on the scaffold was visualized on the scaffold surface using immunocytochemistry;
fibronectin (green), nuclei (blue). Fibronectin deposition is evident after 3 days on all
three scaffold types. After 7 days, fibronectin deposition remains evident on the surface
of all three scaffold types. Images are representative of three independent experiments.
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Figure 2.10 - Biglycan immunoreactivity on the scaffold surface.
The secretion and deposition of the small ECM proteoglycan biglycan by hGFs cultured
on the scaffolds was visualized on the scaffold surface using immunocytochemistry;
biglycan (green), nuclei (blue). Biglycan immunoreactivity was observed intracellularly
after 3 days on all three scaffold types. Biglycan appears most prominent on PCL alone
scaffolds and appears to be diminished in the presence of increasing concentrations of
bFGF. After 7 days of culture, biglycan remains intracellular.
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Figure 2.11 - Decorin immunoreactivity on the scaffold surface.
The secretion and deposition of the small ECM proteoglycan decorin by hGFs cultured
on the scaffolds was visualized on the surface of the scaffold using
immunocytochemistry; decorin (green), nuclei (blue). Decorin is observed on all three
scaffold types at day 3 however appears most prominent in the presence of bFGF.
Decorin remains associated with the cells after 7 days.
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2.3.5

Effect of PCL Electrospun Fibrous Scaffolds Loaded with
bFGF Microspheres on Fibronectin and Biglycan mRNA

Relative mRNA levels of fibronectin (Figure 2.12A) and biglycan (Figure 2.12B) were
assessed following culture on PCL electrospun scaffolds with and without bFGF
microspheres for 3 or 7 days. At both 3 and 7 days, neither fibronectin nor biglycan
mRNA levels on scaffolds with low or high bFGF loaded microspheres was observed to
be significantly different from that of the PCL alone scaffold (Figure 2.12A, B).

2.3.6

Localization of M2 Macrophages in Rat Gingival Wounds
Treated with PCL Electrospun Scaffolds

The next set of experiments were conducted to assess the effect of each scaffold type on
the rate of wound healing in a rat model following gingivectomy. We first determined
the effect of each scaffold type on inflammatory cells, in particular the M2 or
alternatively activated macrophage phenotype, in healing rat gingival tissue following
gingivectomy. At 3 days, macrophages were observed primarily in the region of the
developing granulation tissue in all treatments (Figure 2.13). At 7 days, M2 macrophage
populations appeared more prominent and were observed in the connective tissue around
the crest of the alveolar bone in wounds treated with PCL alone and bFGF loaded
scaffolds, whereas accumulation was predominantly located underneath the junctional
epithelium at the junction of the epithelium with the tooth surface in untreated wounds.

2.3.7

Proliferating Cells in Rat Gingival Wounds Treated with PCL
Electrospun Scaffolds

To determine the effect of the scaffolds on the proliferation of cells in healing rat gingival
tissue, sections were stained for proliferating cell nuclear antigen (PCNA), a marker of
active DNA replication (Figure 2.14A). At 3 days post-wounding, proliferating cells
were observed in the connective tissue at the wound edge for all treatments (Figure
2.14B). In addition, proliferating cells were observed in the basal epithelial cell layer in
all treatments. At 7 days post-wounding, proliferating cells are evident in the connective
tissue and basal epithelial cells in all treatment groups (Figure 2.14B).

Proliferating

cells were quantified and no significant differences were observed between treatments at
3 or 7 days post-wounding (Figure 2.14C)
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Figure 2.12 - Influence of PCL electrospun scaffolds loaded with bFGF on
fibronectin and biglycan mRNA levels.
hGFs were seeded and cultured on PCL electrospun fibrous scaffolds with and without
bFGF microspheres for 3 or 7 days. RNA was isolated and qRT-PCR was performed
using primers specific for FN and BGN. mRNA levels were normalized to endogenous
18S ribosomal RNA levels. A) Release of bFGF from the microspheres did not
significantly alter the levels of fibronectin mRNA from that of the PCL alone scaffold at
3 or 7 days. B) Release of bFGF from the microspheres did not significantly alter the
levels of biglycan mRNA from the PCL alone scaffold at either 3 or 7 days. Graphs
represent mean ± SD of three independent experiments conducted with different patient
cells, with three replicates per experiment. Effect of treatments were analyzed via a twoway ANOVA with a Bonferroni post-test to compare differences between means, p<0.05.
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Figure 2.13 - M2 macrophage localization following in vivo gingivectomy.
Gingivectomy was performed in rats, and wounds were treated with scaffold membranes
of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect).
Localization of arginase 1 (cyan), a marker of M2 macrophages, was visualized with
immunohistochemistry using a Cy5 conjugated secondary antibody with Hoechst dye
counterstaining (blue) to visualize nuclei in the tissue and imaged with fluorescent
microscopy. Images are representative of three individual experiments. A) Arginase 1 is
observed in the granulation tissue at 3 days and in the connective tissue of the gingiva at
7 days. In wounds treated with scaffolds, M2 macrophage populations are localized
around the crest of the alveolar bone. T – Tooth, B – Alveolar bone. B) Higher
magnification images of the areas in A) indicated by white boxes. M2 macrophages
become more abundant at 7 days and in wounds treated with all three scaffold types, M2
macrophages are localized around the crest of the alveolar bone, whereas in the empty
defect they are localized under the junctional epithelium.
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Figure 2.14 - Cell proliferation following in vivo gingivectomy.
Gingivectomy was performed in rats, and defects were treated with scaffold membranes
of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect).
Sections were labelled with a primary antibody for PCNA and visualized with an
appropriate Cy5 conjugated secondary antibody (red) with Hoechst dye counterstain
(blue) to visualize nuclei in the tissue. Images are representative of three independent
experiments. A) Proliferating cells were observed in the connective tissue and basal
epithelial layer for all treatments at both 3 and 7 days post-wounding. T – Tooth, B –
Alveolar bone. Scale bar = 500 µm. B) Higher magnification images of the areas in A)
indicated by white boxes. Proliferating cells are evident in the connective tissue and
basal epithelial cell layer at both 3 and 7 days for all treatments. C) The number of
PCNA positive cells in the wound was quantified at 3 and 7 days post-wounding and
plotted as mean ± SD of three independent experiments. Two-way ANOVA with a
Bonferroni post-test was used to compare means. No significant difference in the number
of PCNA positive cells in the healing wounds were observed between treatments at either
3 or 7 days.
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2.3.8

Myofibroblasts in Rat Gingival Wounds Treated with PCL
Electrospun Scaffolds

Myofibroblasts in healing rat gingival tissue were visualized by immunostaining for αSMA and identified as α-SMA positive fibroblasts in the connective tissue not in the
vasculature (Figure 2.15A, B, Appendix K). Myofibroblasts were observed in the wound
area at 3 days for all treatments and became more abundant at 7 days for all treatments
(Figure 2.15C).

2.3.9

Collagen Deposition in Rat Gingival Wounds Treated with
PCL Electrospun Scaffolds

To visualize the deposition of collagen in healing rat gingival tissue following
gingivectomy, sections were stained with Van Gieson’s stain (Figure 2.16A, B) and
Masson’s trichrome (Figure 2.16C, D). In addition, collagen was visualized in uninjured
tissue and immediately following gingivectomy (Appendix J). At day 3, the original
wound margin is visible using both stains as indicated by the termination of the preexisting thick collagen fibers in the connective tissue. At 7 days, dense collagen
accumulation is noted in the newly formed connective tissue of untreated wounds and
wounds treated with scaffolds containing bFGF. Black arrows indicate areas of dense
collagen accumulation. In the high bFGF treated wound collagen fibers are seen to
extend into the free gingiva.

2.3.10

Connective Tissue Area in Rat Gingival Wounds Treated
with PCL Electrospun Scaffolds

Gingival wounds were assessed at 3 and 7 days post-wounding to quantify the amount of
newly formed connective tissue in the wound area (Figure 2.17A). 3 days post-wounding
granulation tissue was observed in the wound area for all scaffold treatments and the
empty defect (Figure 2.17B). At 7 days, the general architecture of the gingival
connective tissue appeared to be restored in all treatment groups (Figure 2.17A).
Connective tissue area was quantified and no difference was observed between treatment
groups (Figure 2.17B).
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Figure 2.15 - Myofibroblast populations following in vivo gingivectomy.
Gingivectomy was performed in rats, and defects were treated with scaffold membranes
of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect). A)
Sections were labelled with a primary antibody for α-SMA and visualized with an
appropriate Cy5 conjugated secondary antibody (red) with Hoechst dye counterstain
(blue) to visualize nuclei in the tissue. T – Tooth, B – Alveolar bone. Scale bar = 500
µm. B) Higher magnification images of the areas in A) indicated by white boxes. The
number of α-SMA positive myofibroblasts not associated with vasculature in the wound
area were quantified at 3 and 7 days post-wounding and plotted as mean ± SD of three
independent experiments. Two-way ANOVA with Bonferroni’s post-test was used to
compare means. No significant difference in the number of myofibroblasts in the healing
wounds were observed between treatments at either 3 or 7 days.
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Figure 2.16 - Collagen deposition following in vivo gingivectomy.
Gingivectomy was performed in rats, and defects were treated with scaffold membranes
of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect). A)
Collagen was visualized at 3 and 7 days post-gingivectomy using Van Gieson’s staining
(pink). B) Higher magnification images of the areas indicated in A) by the black boxes.
C) Masson’s trichrome staining was used to visualize collagen (blue) in the healing rat
gingival wounds. D) Higher magnification images of the areas indicated in C) by the
black boxes. Images are representative of three independent experiments. Scale bars =
200 µm. At day 3 for all treatments, the boundary of the created wounds is visible as
indicated by the termination of the pre-existing dense collagen fibers in the gingival
connective tissue, labelled with black arrows [B), D)]. 7 days post-wounding, areas of
dense collagen fibers in the newly formed tissues of the untreated and bFGF scaffold
treated wounds were visible, as indicated by black arrows [B), D)].
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Figure 2.17 - Connective tissue area following in vivo gingivectomy.
Gingivectomy was performed in rats, and defects were treated with scaffold membranes
of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect). A)
Area of newly formed tissue in the gingival connective tissue was quantified from H&E
stained histological sections at 3 and 7 days post-wounding. Solid green line indicates
the quantified area of newly formed tissue. Scale bar = 500 µm. B) Newly formed tissue
area was quantified and plotted as mean ± SD of three individual experiments. Newly
formed tissue was observed in the wound area at day 3 for all treatments with increased
tissue area observed at day 7. Two-way ANOVA with Bonferroni’s post-test was used to
compare means. No significant difference in regenerated connective tissue area was seen
between treatments.
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2.3.11

Epithelial Migration in Rat Gingival Wounds Treated with
PCL Electrospun Scaffolds

The distance the epithelium had migrated from the original wound location was measured
in the healing rat gingival tissue from H&E stained sections (Figure 2.18A). At 3 days
post-gingivectomy, the epithelium was observed to have migrated towards the tooth from
the location of the original wound in all treatment groups (Figure 2.18B). Epithelial
migration increased with time and was greater at 7 days than at 3 days for all treatments.
At day 7 the epithelium in all treatment groups was observed to contact the tooth (Figure
2.18A).

2.3.12

Biologic Width of Rat Gingival Wounds Treated with PCL
Electrospun Scaffolds

Histomorphometric analysis of H&E stained rat gingival wound sections was conducted
to determine the biologic width of the healing tissue at 7 days, as at 3 days none of the
wounds were reepithelialized (Figure 2.19A). Connective tissue attachment was
measured from the crest of the alveolar bone to the most coronal attachment of
connective tissue to the tooth. No statistically significant difference in connective tissue
attachments between treatments was observed (Figure 2.19B).
Junctional epithelium length was measured as the second component of the biologic
width of the gingiva. A junctional epithelium was present for all treatments (Figure
2.19A). No statistically significant difference in the length of the junctional epithelium
was observed between treatments (Figure 2.19C).
The biologic width of the gingiva was calculated by the addition of the connective tissue
attachment to the junctional epithelium length. Biologic width between treatments was
not significantly different at day 7 and all groups were observed to have a biological
width similar to that of healthy, uninjured gingival tissue (Figure 2.19D).
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Figure 2.18 - Epithelium length following in vivo gingivectomy.
Gingivectomy was performed in rats, and defects were treated with scaffold membranes
of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect). A)
The length of the epithelium was measured from the original wound from H&E stained
histological sections at 3 and 7 days post-wounding. Solid green line indicates distance
migrated. Scale bar = 500 µm. B) Migration distance was measured and plotted as mean
± SD of three individual experiments. The epithelium migrated from the original wound
towards the tooth at day 3 with epithelial migration distance increasing at day 7 for all
treatments. Two-way ANOVA with Bonferroni’s post-test was used to compare means.
No significant difference in epithelial migration distance was seen between treatments at
3 or 7 days.
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Figure 2.19 - Biologic width measurement following in vivo gingivectomy.
Following gingivectomy in rats, defects were treated with scaffold membranes of PCL
alone, low bFGF loaded, high bFGF loaded or no treatment (empty defect). A) Biologic
width measurements were made from H&E stained histological sections at 7 days postwounding as at 3 days the wounds were not reepithelialized. Horizontal solid green lines
indicate demarcations between measured components as outlined in the methods.
Measured distances are indicated by vertical solid green lines on each section. Scale bar
= 500 µm. B) Connective tissue attachment was measured and plotted as mean ± SD of
three individual experiments. One-way ANOVA with Kruskal-Wallis post-test was used
to compare means. Connective tissue attachment was observed at 7 days for all
treatments with no significant difference between treatments. C) Junctional epithelium
length was measured and plotted as mean ± SD of three individual experiments. One-way
ANOVA with Kruskal-Wallis post-test was used to compare means. At day 7 a
junctional epithelium was present for all treatments with no significant difference in
length between treatments. D) Biological width was calculated as the sum of connective
tissue attachment and junctional epithelium length and plotted as mean ± SD of three
independent experiments. One-way ANOVA with Kruskal-Wallis post-test was used to
compare means. No significant difference in biological width was observed between
treatments.
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2.4

Discussion

GTR employs a cell occlusive barrier membrane to prevent the oral epithelium migrating
along the tooth root into periodontal defects, precluding connective tissue attachment to
the tooth (Karring, Nyman et al. 2000, Polimeni, Xiropaidis et al. 2006). The use of an
occlusive barrier membrane for GTR is not optimal as it physically separates the
periodontal defect from the gingival connective tissue, the latter representing a rich
source of vascular beds (Bartold, Walsh et al. 2000) and potentially cell populations such
as pericytes and mesenchymal progenitor cells which could contribute significantly to
periodontal healing (Fournier, Larjava et al. 2013). Therefore the development of
membranes that would allow gingival connective tissue integration, while maintaining a
barrier to the oral epithelium, would be extremely advantageous. In this study, using
hGFs, human gingival explants and in vivo rat models, we investigated the efficacy of a
porous electrospun fibrous PCL scaffold with microspheres containing bFGF as a
potential new material for periodontal GTR applications.
We utilized polycaprolactone (PCL) as the base polymer for the modified barrier
membrane for several key reasons. Firstly, it is FDA-approved, which allows for faster
clinical translation, and it is already used as a root-end filling material in endodontics (de
Souza Filho, Gallina et al. 2012). Secondly, as we have done, it can readily be
electrospun into fibers to produce a scaffold rather than an impermeable membrane. In
addition, although it is not biodegradable in physiological systems, it is bioresorbable
through hydrolysis of its ester linkages, which typically occurs over a 12-month period
(Woodruff and Hutmacher 2010). As periodontal tissues are slow to regenerate,
hydrolysis over a 12-month period is advantageous.
To assess the efficacy of the scaffold, we first investigated the in vitro response of hGFs
to the scaffolds. SEM revealed that hGFs attached to the fibers of all scaffold types
within 1 hour following seeding on the scaffold surface. The observation of broad cell
extensions and cell spreading indicates strong attachment to the scaffold fibers as nonadherent fibroblasts display a more rounded morphology (Rosen and Culp 1977). Both
cell alignment and orientation are strongly influenced by the underlying topography, in
this case, multiple fibers under each cell (Brunette, Kenner et al. 1983, Brunette 1986,
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Hamilton, Oakley et al. 2009). Cellular orientation in response to aligned electrospun
fibers has been noted for several different cell types and scaffold materials (Baker and
Mauck 2007, Murugan and Ramakrishna 2007, Nisbet, Forsythe et al. 2009, Shang, Yang
et al. 2010). Fiber diameter is a significant factor influencing fibroblast alignment with
the greatest degree of alignment observed along fibers of 10 µm diameter (Hwang, Park
et al. 2009). The PCL electrospun scaffolds used in this study had a fiber diameter of 7.4
± 2.0 µm (Guo, Elliott et al. 2012) and although smaller than 10 µm, still influence hGF
morphology. The significance of cell alignment is considerable, as it is known to alter
downstream cellular processes including proliferation and differentiation, and matrix
deposition (Chou, Firth et al. 1995, Glass-Brudzinski, Perizzolo et al. 2002).
In gingival wound healing, fibroblasts proliferate and migrate into the wound site. PCL
electrospun scaffolds with and without bFGF support an increase in hGF population
growth in vitro as indicated by an increase in cell number on all three scaffold types
tested, in a temporal manner. bFGF is a potent mitogen of fibroblast cells
(Gospodarowicz 1974) and the addition of bFGF microspheres to the scaffold
significantly increases the cell number of hGFs cultured on the scaffold. This suggests
that the addition of bFGF microspheres to PCL electrospun scaffolds enhances the
scaffold bioactivity. Variability in the degree of cell number increase was observed
between patients, which could be attributed to donor patient age (Bartold, Boyd et al.
1986, Caceres, Oyarzun et al. 2014). Future studies will focus on an increased analysis
of cells isolated from patients of different ages. As gingival recession and periodontal
disease predominantly affect more elderly populations, it will be important to quantify if
bFGF release would be effective in the induction of proliferation in cells from patients in
this age range.
As they enter the wound site, hGFs contribute to granulation tissue formation and
synthesize ECM components to replace the provisional matrix (Aukhil 2000, Hakkinen,
Uitto et al. 2000). Fibronectin is the first component of granulation tissue secreted by
fibroblasts (Hakkinen, Uitto et al. 2000) and is found in the gingival tissue in health
(Connor, Aubin et al. 1984, Steffensen, Duong et al. 1992). hGFs cultured on all three
scaffold types were observed to secrete fibronectin onto the scaffold surface after 3 days
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and 7 days of culture on the scaffold. Fibronectin deposition was organized
predominantly in the direction of the cell long axis. It has been previously demonstrated
that fibronectin deposition can be altered by variations in substratum topography, such
that our observations are not unexpected (den Braber, de Ruijter et al. 1998). Fibronectin
mRNA transcript levels were not significantly altered by the release of bFGF from the
microspheres on the PCL electrospun scaffolds, which was unexpected as bFGF has been
shown to increase fibronectin expression in a dose-dependent manner (Xie, Bian et al.
2008).
Decorin, a small leucine-rich proteoglycan, is a major component of gingival connective
tissue where it associates with type I collagen fiber bundles (Hakkinen, Oksala et al.
1993). Decorin is secreted by fibroblasts in culture where it associates with fibronectin
(Schmidt, Robenek et al. 1987). Decorin production by hGFs cultured on PCL
electrospun scaffolds was visible at 3 days and was most notable on the scaffold
containing high bFGF microspheres. Following 7 days of culture, decorin production
appeared localized to the cells, suggesting cells are not actively secreting the
proteoglycan. This is consistent with previous findings that bFGF upregulates decorin
gene expression in dermal fibroblasts (Tan, Hoffren et al. 1993). Finally, we assessed
deposition of biglycan, a small leucine-rich proteoglycan that makes up a minor
component of human gingival connective tissue where it associates with type I collagen
fiber bundles in the deep connective tissue (Hakkinen, Oksala et al. 1993, Alimohamad,
Habijanac et al. 2005). Biglycan production by hGFs on PCL electrospun scaffolds was
evident after 3 and 7 days and appeared to be attenuated in a bFGF dose-dependent
manner. Biglycan gene expression of hGFs cultured on the electrospun PCL scaffolds
was not significantly altered by the release of bFGF from the microspheres. Interestingly,
previous studies have shown that bFGF downregulates biglycan gene expression in
dermal fibroblasts in vitro, suggesting that gingival fibroblasts may differ in response to
bFGF (Tan, Hoffren et al. 1993). Overall, our data demonstrates that PCL scaffolds with
or without bFGF support matrix fibrillogenesis, which will be an important determinant
of regeneration of the connective tissue.
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Ex-vivo gingival explant cultures more closely mimic the in situ environment, as cells
would be required to migrate through the collagenous ECM of the tissue to enter the
scaffold. Therefore, we next investigated whether cells would migrate from explants onto
the scaffold and whether this was influenced by the presence of bFGF. SEM analysis
demonstrated that cell outgrowth from gingival tissue explants was evident on the surface
of all scaffold types. In tissue sections, bFGF release significantly promoted scaffold
infiltration by mesenchymal cells (vimentin+ cells) compared to PCL alone scaffolds,
with increased cell number correlated with higher bFGF concentrations. We chose bFGF
primarily because it is a potent chemotactic agent for fibroblast cells (Buckley-Sturrock,
Woodward et al. 1989) and based on the increased cell number seen within the scaffolds
containing both low and high bFGF, it appears to function when released from the
microspheres. However, bFGF is also a potent mitogen for fibroblast cells
(Gospodarowicz 1974) and cell proliferation within the scaffold cannot be eliminated as a
contributing factor to the increase in cell population in the presence of bFGF
microspheres. To investigate the individual contribution of migration and proliferation to
scaffold population in future studies, proliferation of cells within the explant tissue will
be inhibited using mitomycin C (Tomasz 1995). However, as we hypothesized,
mesenchymal cells from the gingival connective tissue are able to infiltrate the scaffolds
through the pores.
Oral epithelial cells are known to migrate quickly in vivo (Hamilton, Chehroudi et al.
2007). As highlighted previously, conventional GTR membranes are cell-occlusive and
are designed to block this aggressive migration into the pocket (Needleman, Worthington
et al. 2006). While the scaffolds supported the infiltration of mesenchymal cells, they
excluded the infiltration of oral epithelial cells. Oral epithelial cells found at the interface
between the scaffold and the explant tissue were observed to migrate along the surface of
the scaffold as a sheet with minimal infiltration below the surface of the scaffold. We
attribute this to the pore size of the scaffolds (17.1 ± 8.3 µm with pore size ranging from
6.8 – 47.2 µm (Guo, Elliott et al. 2012)). The function of epithelial cells in vivo is to
form coverings and linings over tissues. In vitro epithelial cells tend not to migrate into
pitted topographies and rather form coverings over pits with dimensions of 45 µm2
openings (Hamilton, Chehroudi et al. 2007). bFGF stimulates the proliferation of
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gingival epithelial cells in a dose-dependent manner, however the stimulation is
somewhat attenuated in the presence of serum (Takayama, Yoshida et al. 2002). In the
current study, epithelial cells did not penetrate scaffolds even in the presence of bFGF
release from the microspheres, however on high bFGF loaded scaffolds the epithelial
layer appeared larger, likely in a state of hyperproliferation. Both topical and sustained
release of bFGF in palatal wound healing in vivo has been shown to accelerate wound
epithelialization and increase the proliferation of basal epithelial cells (Oda, Kagami et al.
2004, Ayvazyan, Morimoto et al. 2011). The morphology of the healing epithelial layer
following topical application of bFGF was found to be morphologically similar to that of
the control wounds (Oda, Kagami et al. 2004), however bFGF administration using a
sustained method increased the epithelial ridges observed as compared to the control
(Ayvazyan, Morimoto et al. 2011). The sustained release of bFGF from the microspheres
in the PCL electrospun scaffolds used in this study may account for the observed
differences in epithelial sheet thickness from the tissue explants. Of particular
significance is the observation that the PCL electrospun scaffold excludes oral epithelial
cells. This result has significant implications for membrane design as it demonstrates that
it is not necessary for GTR membranes to be completely cell-occlusive to prevent the
migration of the oral epithelium. As has been previously demonstrated, the strict
occlusion of the gingival connective tissue from a regenerating periodontal defect is not a
critical requirement for the successful regeneration of periodontal structures (Wikesjo,
Lim et al. 2003); however, occlusion of the oral epithelium is (Linghorne and O'Connell
1950). Our scaffolds accomplish this as indicated by the infiltration of and population by
cells of mesenchymal origin while simultaneously maintaining a barrier to oral epithelial
cells.
Based on their efficacy in vitro, we next assessed each scaffold type in a rat gingivectomy
model, with healing responses at 3 and 7 days investigated. The initial stage of wound
healing is characterized by an inflammatory response and inflammatory responses are
commonly elicited following the implantation of biomaterials (Polimeni, Xiropaidis et al.
2006, Garg, Pullen et al. 2013). The regenerative, alternatively activated M2 phenotype
macrophages are typically associated with tissue repair and the polarization of
macrophages to the M2 phenotype is influenced by scaffold architecture, therefore we

113

investigated the M2 macrophage response following treatment with PCL electrospun
scaffolds (Fairweather and Cihakova 2009, Garg, Pullen et al. 2013). In all wounds, M2
macrophage populations were prominent in the connective tissue at 7 days postwounding and were localized under the junctional epithelium in untreated wounds.
However, in scaffold treated wounds, M2 macrophage populations were observed around
the crest of the alveolar bone, although the presence of bFGF appeared to have no effect
on macrophage persistence. Although bFGF is not proinflammatory, studies have shown
that under inflammatory conditions in dermal tissues bFGF potentiates the recruitment of
inflammatory cells (Zittermann and Issekutz 2006). However, our results are consistent
with the observation that the addition of bFGF to a collagen scaffold implanted in rat
palatal submucoperiosteal tissue did not alter the inflammatory response. The scaffolds
used in this study had a mean pore diameter of 17.1 ± 8.3 µm with pore size ranging from
6.8 – 42.7 µm (Guo, Elliott et al. 2012) which has been shown in other studies to be
favourable for M2 macrophage polarization in the early inflammatory response (Garg,
Pullen et al. 2013). In addition, scaffolds with aligned fibers minimized host response
compared to randomly oriented fibers (Cao, McHugh et al. 2010).
We next assessed whether the presence of bFGF within the scaffolds influenced cell
proliferation. In the healing gingival tissue, proliferating cells were observed in the
epithelium and connective tissue for all treatments at both 3 and 7 days post-wounding.
The presence of bFGF at both low and high loading did not significantly alter the number
of proliferating cells at either 3 or 7 day post-wounding compared to both the empty
defect and the PCL alone scaffold. Since bFGF is a potent mitogen and exhibits
stimulatory effects on gingival epithelial cell proliferation, increased cell proliferation in
healing rat gingival wounds treated with PCL electrospun scaffolds containing bFGF
would be expected (Gospodarowicz 1974, Takayama, Yoshida et al. 2002). The
mitogenic effects of bFGF have been demonstrated following topical application to oral
mucosa wounds wherein an increase in the number of proliferating basal epithelial cells
was noted and at higher concentrations proliferation of cells within the connective tissue
was evident (Oda, Kagami et al. 2004). Myofibroblasts, characterized by α-SMA
expression, are transiently present during wound healing and contribute to matrix
production and contraction, however persistence of myofibroblasts is associated with scar
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formation and fibrosis (Shi, Lin et al. 2013). bFGF treatment downregulates α-SMA
gene expression and induces apoptosis of both dermal and oral mucosal myofibroblasts
(Funato, Moriyama et al. 1997, Funato, Moriyama et al. 1999, Shi, Lin et al. 2013). In
the current study, myofibroblasts in the healing rat gingiva treated with PCL electrospun
scaffolds were observed at 3 days and became more abundant at 7 days. The presence of
bFGF on the scaffolds did not significantly alter the number of myofibroblasts observed
in the healing rat gingival wounds. This is unexpected as bFGF induces the apoptosis of
myofibroblasts and studies have shown that the addition of bFGF to collagen scaffolds
implanted in the submucosal tissue of the rat palate reduce the number of myofibroblasts
observed within and around the scaffold at 7 and 14 days following implantation (Funato,
Moriyama et al. 1997, Funato, Moriyama et al. 1999, Jansen, van Kuppevelt et al. 2009).
It is possible that the scaffolds used in this study may show an effect at a later time point,
such as 14 days post-wounding, as myofibroblast differentiation in a healing wound
generally occurs around day 6 and populations accumulate until day 15 where
myofibroblasts comprise 70% of granulation tissue fibroblasts (Darby, Skalli et al. 1990,
Hakkinen, Uitto et al. 2000).
During granulation tissue formation, fibroblasts initially secrete fibronectin which is
gradually replaced with a fibrillar type I collagen matrix (Kurkinen, Vaheri et al. 1980,
Hakkinen, Uitto et al. 2000). In the present study, we investigated the collagen
deposition in rat gingival wounds using histochemical staining. At 7 days post
wounding, dense collagen accumulation is observed in the connective tissue of untreated
wounds and wounds treated with scaffolds containing bFGF. Studies of healing rat
palatal wounds found that treatment with topical bFGF application resulted in the
formation of mature collagen fibers in the granulation tissue adjacent to the pre-existing
fibers at 7 days post-wounding whereas mature collagen fibers were absent in untreated
control wounds suggesting that bFGF may accelerate the maturation of collagen (Oda,
Kagami et al. 2004). Studies looking at longer time points of 6 weeks found that
following mucoperiosteal denudation of the rat palate, collagen accumulation was
decreased in the submucosa of the gingiva in wounds receiving a topical application of
bFGF (Choi, Kawanabe et al. 2008). In this study, collagen deposition was evident in the
gingival connective tissue at 7 days and future studies using longer time points would be
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of interest to investigate collagen deposition in response to scaffold membrane treatment
following tissue remodeling.
Treatment with the scaffold membranes did not have a significant effect on the area of
granulation tissue formed at 3 days, the area of connective tissue regenerated at 7 days or
the length of the neoformed epithelium at 3 or 7 days. This is unexpected as studies have
shown topical bFGF applications to rat palatal wounds increases the rate of granular
tissue formation and reepithelialization of these wounds (Oda, Kagami et al. 2004).
However, the concentration used for topical application was greater (0.5 and 3.0 µg) than
that of the scaffold used (~25 ng cumulative release over 7 days from a 50 mg piece of
high bFGF loaded scaffold (Guo, Elliott et al. 2012)). In this study, treatment with PCL
scaffold membranes did not significantly affect the biologic width of the reepithelialized
wound at day 7. Taken together, these results suggest that the scaffolds are
biocompatible for use as a GTR membrane.
bFGF exerts its effects in a dose-dependent manner (Gospodarowicz 1974, Takayama,
Murakami et al. 2001, Ayvazyan, Morimoto et al. 2011, Ma, Wang et al. 2012) therefore
this study looked at two loading doses of bFGF on the PCL scaffolds. In vitro, high
bFGF loading appeared to be more effective for population of the scaffolds by
mesenchymal cells from gingival tissue explants as compared to the low bFGF loading
dose, whereas experiments in which a finite cell number was seeded onto the scaffolds,
the low bFGF loading dose promoted a greater increase in cell number. bFGF loading
dose did not significantly alter the mRNA expression levels of fibronectin or biglycan.
When tested in vivo the two loading doses of bFGF were not significantly different for
any of the parameters tested: proliferating cell number, myofibroblast number, connective
tissue area, neoformed epithelium length or biologic width. These results suggest that the
loading dose of bFGF in the microspheres of PCL scaffold membranes for use in
periodontal regeneration could be optimized to determine the concentration which
promotes accelerated would healing in vivo. In addition, for translation to clinical
studies, dosing would need to be further optimized. bFGF in the microspheres was
stabilized by heparin (Nissen, Shankar et al. 1999) and retains its biological activity
following release from the microspheres (Guo, Elliott et al. 2012), however over time the
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age of the scaffold may have contributed to a loss of bioactivity of the bFGF in the
microspheres.

2.5

Conclusion

In conclusion, we have shown that PCL electrospun fibrous scaffolds are biocompatible
when tested in vitro with hGFs as evidenced by cellular attachment, increase in cell
number with time and matrix deposition, and when tested with gingival tissue explants ex
vivo as indicated by population of the fibrous construct by mesenchymal cells. The
release of bFGF from microspheres contained within the PCL scaffolds promotes the
population of the scaffolds by mesenchymal cells from gingival tissue explants and
increases hGF cell number on the scaffolds. Importantly, the scaffolds were found to act
as a barrier to oral epithelial cells in vitro, as indicated by minimal epithelial cell
penetration into the scaffold interior. In vivo all three scaffold types were found to be
biocompatible in a rat model of gingival repair. These results suggest that with further
optimization for in vivo testing, PCL electrospun scaffolds show promise as a bioactive,
porous GTR membrane alternative.
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Chapter 3

3

General Discussion
3.1

Summary and Conclusions

Objective #1: To characterize the influence of PCL electrospun fibrous scaffolds
loaded with bFGF microspheres on human gingival fibroblasts in vitro and
gingival tissue ex vivo
a. Assess human gingival fibroblast attachment, proliferation and matrix
synthesis and deposition on PCL electrospun scaffolds loaded with
bFGF
In this study, hGFs were found to attach and spread on all three scaffold types
with cell morphology being influenced by the fibers of the scaffold. All three
scaffolds supported an increase in hGF cell number temporally with bFGF
loading promoting an increase in cell number. Qualitative assessment of ECM
deposition on the surface of the scaffolds using immunocytochemistry revealed
that hGFs secreted a fibronectin matrix onto the scaffolds both with and without
bFGF loading, whereas biglycan and decorin remained mainly intracellular on all
scaffolds. bFGF did not alter the deposition of fibronectin appreciably, however
appeared to reduce biglycan immunoreactivity and increase decorin
immunoreactivity. Neither bFGF concentration significantly altered fibronectin
or biglycan mRNA levels.
b. Assess cell infiltration from gingival tissue explants into PCL
electrospun scaffolds loaded with bFGF
In this set of experiments, cells of mesenchymal origin, vimentin+, were found to
populate the PCL electrospun scaffolds with cell density increasing in a bFGF
dose-dependent manner. Oral epithelial cells from the explant tissue were found
to remain on the surface of the scaffold with little penetration into the scaffold
interior observed on both PCL alone and high bFGF loaded scaffolds.
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Taken together, these results suggest that the PCL electrospun scaffolds loaded
with bFGF are able to act as an epithelial cell-occlusive membrane while
facilitating interaction with hGFs and mesenchymal cells.
Objective #2: Assess the influence of PCL electrospun fibrous scaffolds loaded
with bFGF microspheres on the rate of wound healing following gingivectomy in
a rat model
In a rat gingivectomy model, treatment with PCL electrospun scaffolds localized
populations of alternatively activated M2 phenotype macrophages around the
crest of the alveolar bone. Scaffolds both with and without bFGF loading did not
significantly change the number of proliferating cells or myofibroblasts in the
healing wound. Collagen deposition was observed in the regenerating gingival
connective tissue at day 7 in wounds treated with scaffolds loaded with bFGF.
The area of newly formed connective tissue, epithelial length and biologic width
did not show any significant difference in wounds treated with any scaffold type.
The results of this study suggest that PCL scaffolds both with and without bFGF
loading are biocompatible in a model of gingival healing.

3.2
3.2.1

Contributions to the Current State of Knowledge
General Significance

Periodontal diseases are highly prevalent in the Western population and require surgical
intervention to halt disease progression and induce regeneration of the lost tissues. GTR
procedures are currently used as a surgical method to regenerate the periodontium, but
the membranes currently employed are cell-occlusive and when used clinically, results
have been variable and unpredictable (Chen and Jin 2010). Functionally excluding the
gingival connective tissue from the regenerating defect is suboptimal as it excludes the
rich vascular plexus, pericytes and progenitor cells of the gingival connective tissue
which could aid in the regeneration of the damaged periodontium (Schroeder and
Listgarten 1997, Fournier, Larjava et al. 2013). Exclusion of the oral epithelium from the
regenerating periodontal defect is a requirement for the formation of a new connective
tissue attachment to the tooth root (Polimeni, Xiropaidis et al. 2006), but exclusion of the
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collagenous gingival connective tissue itself arises only from the need to block oral
epithelial migration (Wikesjo, Lim et al. 2003). Therefore the focus of this work was the
development of a fibrous and bioresorbable scaffold as an alternative to cell-occlusive
barrier membranes to allow recruitment of mesenchymal cells from the gingival
connective tissue while maintaining a barrier to oral epithelial cells. We demonstrate that
PCL electrospun scaffolds allow the infiltration of mesenchymal cells while
simultaneously posing a barrier to oral epithelial cell infiltration, with the addition of
bFGF promoting mesenchymal cell population and an increase in hGF cell number on the
scaffolds. In vivo, the scaffolds were biocompatible in terms of the polarization of
macrophages to a healing M2 phenotype, collagen deposition, connective tissue
regeneration and biological width restoration.

3.2.2

Role of Scaffold Architecture in Determining Cellular
Responses

It has been established that cells cultured on three dimensional substrates show numerous
behavioral alterations including changes in adhesion, cytoskeletal organization,
proliferation, morphology, and differentiation compared to cells in two dimensional
culture (Friedl and Brocker 2000, Hakkinen, Harunaga et al. 2011, Rampichova, Chvojka
et al. 2013). Furthermore, the physical properties of the scaffolds themselves, such as
fiber diameter, fiber orientation, and porosity play a significant role in the regulation of
cellular morphology, proliferation, alignment, and migration of cells (Liu, Ji et al. 2009,
Shang, Yang et al. 2010). Fibroblast cells show preferential orientation along fibers of 10
µm diameter (Hwang, Park et al. 2009) with hGFs showing alignment along the 7.4 ± 2.0
µm fibers under investigation in this thesis. Porosity of the scaffold is another feature
which has significant effects upon cell behavior. Optimal porosity allows for exchange
of nutrients and wastes within the three dimensional scaffold facilitating development of
a microenvironment for cellular growth (Rampichova, Chvojka et al. 2013). For optimal
cell proliferation, a pore size of between 6 -20 µm has been established for fibroblast
cells. As shown in this thesis, hGF cell number increases with time on the PCL
electrospun scaffolds (pore size 17.1 ± 8.3 µm, pore size range of 6.8 – 42.7 µm).
Porosity also dictates the level of matrix production by cells. Larger pore sizes result in

127

cells attaching to single fibers slowing ECM production as opposed to cells spanning
across multiple fibers (Lowery, Datta et al. 2010). As demonstrated in this thesis, hGFs
attach to and span across multiple scaffold fibers and secrete a fibronectin matrix.
Porosity strongly influences cell migration into the interior of the scaffold, with small
pore sizes excluding cells (Lowery, Datta et al. 2010). The PCL electrospun scaffolds
under study in this thesis allow for infiltration of mesenchymal cells into the scaffold
interior and, of particular significance in terms of GTR membrane design, the scaffolds
were observed to exclude oral epithelial cells. As we have previously demonstrated, oral
epithelial cells do not migrate into topographies of 45 µm2 (Hamilton, Chehroudi et al.
2007). Thus in vitro testing suggests that the porous, fibrous nature of the PCL
electrospun scaffold shows improvement over current cell-occlusive GTR membranes in
that it allows for attachment, cell number increase, and matrix deposition of hGFs and
infiltration of mesenchymal cells while maintaining a barrier to oral epithelial cells.

3.2.3

Role of bFGF in Scaffold Bioactivity

bFGF is a potent mitogen of mesoderm derived cells and a potent chemotactic agent for
fibroblasts (Gospodarowicz 1974, Buckley-Sturrock, Woodward et al. 1989). Topical
application of bFGF has been shown to accelerate oral wound healing (Fujisawa,
Miyamoto et al. 2003, Oda, Kagami et al. 2004), however this method of application in
periodontal defects is problematic as high concentrations of the growth factor are
required to overcome the short half-lives resulting from enzymatic degradation and quick
metabolization following application (Sun, Qu et al. 2012). Suitable carriers are needed
for the temporally sustained release of growth factors at a defect site. In this thesis bFGF
was stabilized with heparin and encapsulated in PLGA microspheres which were
electrosprayed throughout the thickness of the fibrous PCL scaffold. This method of
growth factor delivery allows for a slow and temporally sustained release of the growth
factor as the PLGA shell degrades (Guo, Elliott et al. 2012). bFGF release from the
microspheres increased the bioactivity of the scaffolds when tested in vitro as indicated
by increased hGF number on scaffolds containing bFGF and increased mesenchymal cell
density from gingival tissue explants. Comparison of the two loading doses of bFGF
suggest that the high loading dose of bFGF was more effective for scaffold population by

128

mesenchymal cells from ex vivo gingival tissue explants, whereas the low loading dose
promoted the greatest increase of hGF cell number on the scaffolds. In addition, high
bFGF loading was found to dramatically upregulate versican mRNA expression levels at
14 days of culture in previous experiments. Taken together, these results suggest that
bFGF release from the scaffolds increased their bioactivity when tested in vitro.

3.2.4

PCL Electrospun Scaffolds Loaded with bFGF for Tissue
Repair

As the PCL electrospun scaffolds proved to be oral epithelial cell occlusive and allowed
for infiltration of mesenchymal tissue in vitro they were subsequently tested for their
ability to promote gingival tissue regeneration. The gingiva is a critical component of the
periodontium that functions to protect the underlying structures of the periodontium from
the multitudes of bacterial species present in the oral environment (Schroeder and
Listgarten 1997). This is accomplished through the junctional epithelium of the gingiva
forming a functional seal around the teeth along with adequate connective tissue
attachment to the roots of the teeth. If the gingiva becomes compromised, due to the
repeated inflammatory insult associated with periodontitis, regeneration of the lost
functional structure requires therapeutic intervention, such as GTR (Karring, Nyman et
al. 2000) . GTR procedures are based upon the concept of cell occlusion, specifically the
oral epithelium, from a regenerating periodontal defect to allow for the reformation of
connective tissue attachment to the tooth root (Karring, Nyman et al. 2000). This is
accomplished using occlusive membranes which also exclude the gingival connective
tissue eliminating the rich vascular plexus and associated progenitor cells of the
connective tissue from contributing to periodontal regeneration (Schroeder and Listgarten
1997, Wikesjo, Lim et al. 2003, Fournier, Larjava et al. 2013). In this thesis we have
demonstrated that PCL electrospun fibrous scaffolds are biocompatible when used as an
alternative GTR membrane in terms of macrophage polarization to a reparative M2
phenotype, collagen deposition, connective tissue area regenerated, and connective tissue
attachment, however the role of bFGF release from the scaffolds on the healing process
remains to be fully quantified.
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In addition to their use in periodontal regeneration, the scaffolds may also serve to
facilitate dermal wound healing. bFGF accelerates and plays a role in the reduction of
scar formation, which is a common clinical problem associated with dermal wound
healing (Akita, Akino et al. 2008, Shi, Lin et al. 2013). Sustained release of bFGF from
the scaffold may regulate the apoptosis of myofibroblasts and regulate ECM deposition
thus lessening scar formation (Shi, Lin et al. 2013). In addition, the scaffolds may be
useful at promoting wound healing in diabetic patients, both in dermal and oral mucosal
tissues, as topical bFGF application is shown to be effective at promoting wound healing
in chronic diabetic wounds (Tan, Xiao et al. 2008). One of the complications of diabetes
is deficiencies in wound healing characterized by impairment of the inflammatory
response, granulation tissue formation and angiogenesis (Desta, Li et al. 2010).
Fibroblasts show increased apoptosis in diabetic gingival wounds which is postulated to
play a role in the impaired wound healing response (Desta, Li et al. 2010). Since bFGF is
a potent mitogen for fibroblast cells, sustained release of bFGF from the scaffolds in a
diabetic wound may serve to increase fibroblast proliferation thus rescuing granulation
tissue formation. The porous, fibrous architecture of the scaffold would serve as a
support for cells infiltrating from the granulation tissue until the cells secrete their own
matrix.

3.3
3.3.1

Future Directions
Adhesion Dynamics of Cellular Interaction with PCL
Electrospun Scaffolds

Cells attach to and interact with the extracellular matrix through adhesion sites. These
adhesion sites serve as transmembrane linkages between the extracellular matrix and the
cytoskeleton (Burridge, Molony et al. 1987). Adhesion is mediated through integrins
which function as cell signaling molecules and can affect a diverse range of cell functions
such as migration, proliferation, differentiation, and cell polarity (Streuli 1999, Friedl and
Brocker 2000, Berrier and Yamada 2007). Of particular importance is the response of
cells to three dimensional substrates (Friedl, Zanker et al. 1998, Friedl and Brocker
2000), such as the PCL electrospun scaffolds under investigation in this thesis. To
investigate the adhesion dynamics of hGFs on the PCL electrospun scaffolds, both with
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and without bFGF, indirect immunofluorescence will be used to localize adhesion
structures such as focal adhesion and focal complexes (vinculin, phosphorylated FAK,
phosphorylated paxillin) and fibrillar adhesions (tensin, integrin α5β1) (Berrier and
Yamada 2007) at 3 hours, 6 hours and 7 days post-seeding. Due to the three dimensional
structure of the scaffolds, confocal microscopy will be used to visualize labelled adhesion
molecules thus giving information about the composition, localization, and size of the
adhesions within the cell. To further assess adhesion dynamics on the scaffolds, antibody
inhibition assays will be conducted. hGFs will be incubated with monoclonal antibodies
to integrins α5β1 (three dimensional adhesions) and αvβ3 (two dimensional adhesions)
prior to seeding on all three scaffold types. Cells will be allowed to attach to the
scaffolds for 2 and 24 hours to assess early and late attachment, respectively. At each
time point non adherent cells will be gently removed by rinsing and cell number on the
scaffold will be assessed using an assay to quantify DNA content, such as the
CyQUANT® assay, and compared to cells incubated with vehicle alone prior to seeding.
Adhesion dynamics allow cells to interact with the underlying substratum and ECM,
which in turn dictates ECM production (Mann, Tsai et al. 1999, Lowery, Datta et al.
2010). Characterization of the adhesion dynamics of hGFs on the scaffolds will allow for
determination of the optimal fiber diameter of the scaffolds in order to promote matrix
formation.

3.3.2

Effect of Lipopolysaccharide on hGF Interaction with PCL
Electrospun Scaffolds

Wound healing and periodontal regeneration takes place under exposure to several
bacterial species as the oral environment is home to several hundreds of distinct
microbial species and is one of the most densely populated areas of the body by bacteria
(Takahashi 2005). Bacteria and their products can have a significant impact on wound
healing and cellular response, and thus should be considered when modelling gingival
wound healing in vitro. Porphyromonas gingivalis (P. gingivalis) has been implicated in
the etiology of periodontitis (Moore and Moore 1994) and lipopolysaccharide (LPS), a
bacterial cell wall component, has been postulated to be a likely candidate for activation
of the host inflammatory response (Kocgozlu, Elkaim et al. 2009). Oral epithelial cells
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and gingival fibroblasts produce inflammatory cytokines in response to P. gingivalis LPS
stimulation (Wang and Ohura 2002, Kocgozlu, Elkaim et al. 2009). Fibroblasts show
dose dependent responses to Actinobacillus actinomycetemcomitans (A.
actinomycetemcomitans) LPS with high concentrations inhibiting DNA synthesis
whereas a slight stimulation of DNA synthesis was observed when exposed to low
concentrations (Hill and Ebersole 1996). Furthermore, A. actinomycetemcomitans LPS
stimulation at high concentrations attenuated cell proliferation in response to bFGF
whereas stimulation with low concentrations of A. actinomycetemcomitans LPS enhanced
cell proliferation in response to bFGF (Hill and Ebersole 1996). The LPS of P.
gingivalis differs structurally from that of other Gram-negative bacteria (Wang and
Ohura 2002), thus future experiments to assess the effects of LPS on hGFs cultured on
the PCL electrospun scaffolds will be undertaken using P. gingivalis LPS and A.
actinomycetemcomitans LPS, at both low (< 9 µg) and high concentrations (≥ 9 µg). Cell
number on PCL electrospun scaffolds with and without bFGF loading will be assessed in
the presence of both species of LPS at both concentrations using a CyQUANT® assay to
assess DNA content. These experiments will allow us to gain insight into the potential
effectiveness of the scaffolds under more physiologically relevant and challenging
conditions which are present during periodontal regeneration.

3.3.3

Analysis of PCL Electrospun Scaffolds on Initial and Late
Wound Healing Response

In this thesis we have analyzed the initial gingival wound healing response of rats treated
with PCL electrospun scaffolds both with and without bFGF loading using histological
sections for morphometric analysis and assessing collagen deposition and
immunohistochemistry to analyze proliferating cell number, M2 macrophage polarization
and myofibroblast number. To further analyze the influence of the scaffolds on the
biomolecular events occurring during gingival wound healing, scaffolds would be placed
in the wounds and at 3 and 7 days post-wounding, gingival tissue would be harvested and
mRNA isolated to look for changes in mRNA expression levels of ECM proteins such as
collagen, fibronectin, tenascin-C, biglycan, deocrin and versican. In addition, α-SMA
mRNA expression levels could be analyzed to assess myofibroblast presence in the
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healing wound. The protein level of the previously listed ECM molecules and α-SMA
could be analyzed using Western blots following protein isolation from the tissues.
To characterize the late wound healing response, longer time-points will be used, such as
2, 4 and 6 weeks. During wound healing, myofibroblast differentiation occurs between 6
and 15 days post-wounding with maximal myofibroblast population density observed at
15 days (Darby, Skalli et al. 1990). Since bFGF has been shown to induce the apoptosis
of myofibroblasts (Funato, Moriyama et al. 1997, Funato, Moriyama et al. 1999, Kanda,
Funato et al. 2003) it will be of interest to analyze the effects of the PCL electrospun
scaffolds loaded with bFGF on myofibroblast population in the healing rat gingival
wounds at the later time points of 14 and 28 days which could be accomplished using
immunohistochemistry for localization of myofibroblasts in the healing wound, or with
qRT-PCR and Western blots to examine the mRNA and protein expression level of αSMA, respectively. Although occurring to a lesser extent than in dermal tissue, gingival
tissue following healing may exhibit a denser than normal collagen-rich extracellular
matrix which is particularly problematic if the maxilla is not fully developed (Choi,
Kawanabe et al. 2008). Since bFGF has been implicated in reducing collagen
accumulation during oral wound healing (Choi, Kawanabe et al. 2008), investigation of
collagen deposition at later time points would allow for assessment of the effect of the
PCL electrospun scaffolds with and without bFGF on the deposition and remodeling of
collagen in the healing rat gingiva. This will be accomplished using tissue sections
stained with Masson’s trichrome, Van Gieson’s stain and picrosirius red to allow for
qualitative assessment of collagen deposition. Collagen content in the healing tissues
will be assessed using a hydroxyproline assay on healing tissue homogenates. As
hydroxyproline is almost exclusively found in collagen, this assay will give a quantitative
measure of the collagen content of the tissue (Reddy and Enwemeka 1996).

3.3.4

Assessing Cell Recruitment During Healing – Lineage
Tracing to Assess the Role of Pericytes

During wound healing, extracellular matrix is deposited and the wound is contracted
through the actions of myofibroblasts (Hinz and Gabbiani 2010). Interest in determining
the source of myofibroblast populations in the healing wound have led to studies
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implicating pericytes as a progenitor cell to the myofibroblast (Greenhalgh, Iredale et al.
2013). Pericytes are periendothelial cells found encircling the endothelial cells of the
microvasculature (Greenhalgh, Iredale et al. 2013). Lineage tracing experiments have
identified cells in the perivascular space which are induced upon injury and are profibrotic (Dulauroy, Di Carlo et al. 2012). Since myofibroblasts contribute to wound
healing and are responsible for scar formation and fibrosis which contributes to gingival
recession, it is of interest to analyze their recruitment during gingival regeneration and in
response to scaffold treatment. This will be accomplished using forkhead transcription
factor FoxD1-Cre knock-in mice to allow for lineage tracing of pericytes. In this model,
a fusion protein of Cre recombinase and GFP will be expressed under the control of the
FoxD1 locus (Humphreys, Lin et al. 2010). Gingivectomy will be performed in these
mice and PCL electrospun scaffolds with and without bFGF loading will be placed in the
defect. At time points of 3, 7, 14 and 28 days, wounds will be assessed using histological
sections to localize and quantify differentiated pericytes in the stroma of the regenerating
gingival tissue. This will allow for determination of the role of pericytes in contributing
to myofibroblast populations in gingival tissue and the role of bFGF on these populations.

3.4

Limitations

As with any scientific study, there are several limitations to this work. Working with a
three dimensional scaffold material poses challenges for reliable quantification of certain
parameters. One such consideration is the quantification of cell number from a three
dimensional culture (Ng, Leong et al. 2005). This was accounted for and the CyQUANT
assay was used to give a measure of DNA content on the scaffolds, thus giving the most
accurate measure of cell number. Another concern is the need for a homogenous cell
suspension from which the quantifications are made, which was taken into consideration
and vigorous vortexing was employed to account for cells within the scaffold interior. In
this study we used immunofluorescence as a qualitative measure of assessing ECM
deposition on the surface of the scaffolds, and although Western blot analysis could give
a quantitative assessment of ECM secretion, this technique may be impractical for use
with the three dimensional scaffolds. Although decorin and biglycan are small (36 kDa
and 38 kDa, respectively) (Fisher, Termine et al. 1989, Hering, Kollar et al. 1996),
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fibronectin is secreted as a dimer composed of two monomers of molecular weight 220250 kDa (Potts and Campbell 1994). The large molecular weight of fibronectin may
impede its removal from the fibrous scaffold making it difficult to obtain complete
protein removal from the scaffolds to ensure accurate quantification.
The studies completed herein assumed that the bFGF released from the microspheres was
at a sufficient concentration for in vivo experiments based on results from our in vitro and
ex-vivo studies. However in vivo, the effects were non-significant which could be due to
a sub-optimal concentration of bFGF. Although our laboratory has previously
demonstrated that the scaffolds stimulate angiogenesis in a mouse subcutaneous model,
in vivo fibrogenic response was not investigated (Guo, Elliott et al. 2012). Further studies
using scaffolds loaded with a wider range of bFGF concentrations could confirm this.

3.5

Final Summary

The results presented in this thesis demonstrate that PCL electrospun scaffolds loaded
with bFGF support the attachment, matrix deposition and proliferation of hGFs with
bFGF increasing cell number in a temporal manner. The scaffolds are selectively cell
permeable in that they support the infiltration of mesenchymal cells from gingival tissue
while simultaneously excluding the infiltration of oral epithelial cells. The scaffolds
exhibit biocompatibility in the early stages of gingival wound healing in the rat. This
research suggests that PCL electrospun scaffolds, with or without bFGF microspheres,
represent an alternative to the current cell-occlusive membranes used for GTR.
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Appendix and Curriculum Vitae
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Appendix A: Animal protocol approval.
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Appendix B: Human ethics approval.
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Appendix C: Fibronectin immunoreactivity on the scaffold surface at low
magnification.
The secretion and deposition of the structural ECM protein fibronectin was visualized
with immunocytochemistry; fibronectin (green), nuclei (blue). No fibronectin deposition
is evident at 6 hours of culture for all three scaffold types. Fibronectin deposition
becomes evident after 3 days of culture and remains visible after 7 days of culture.
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Appendix D: No primary antibody negative control fibronectin
immunofluorescence.
The secretion and deposition of the structural ECM protein fibronectin was visualized
with immunocytochemistry; fibronectin (green), nuclei (blue). Negative control images
in which no primary antibody was added were used to set the threshold value for
fibronectin fluorescence. A) Low magnification negative control images. B) High
magnification negative control images.
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Appendix E: Biglycan immunoreactivity on the scaffold surface at low
magnification.
The production of the ECM proteoglycan biglycan was visualized with
immunocytochemistry; biglycan (green), nuclei (blue). Minimal biglycan
immunoreactivity is detected at 6 hours of culture for all three scaffold types.
Intracellular biglycan becomes evident by 3 days on all three scaffold types and appears
diminished in the presence of bFGF release. Intracellular biglycan immunoreactivity is
also observed at 7 days.
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Appendix F: No primary antibody negative control biglycan immunofluorescence.
The production of the ECM proteoglycan biglycan was visualized with
immunocytochemistry; biglycan (green), nuclei (blue). Negative control images in which
no primary antibody was added were used to set the threshold value for biglycan
fluorescence. A) Low magnification negative control images. B) High magnification
negative control images.
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Appendix G: Decorin immunoreactivity on the scaffold surface at low
magnification.
The production of the small ECM proteoglycan decorin was visualized with
immunocytochemistry; decorin (green), nuclei (blue). Decorin immunoreactivity is
observed on all three scaffold types at 6 hours. Decorin is observed on all three scaffold
types at day 3 however appears less prominent on the PCL alone scaffold. Decorin
appears localized to the cells after 7 days of culture.
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Appendix H: No primary antibody negative control decorin immunofluorescence.
The production of the ECM proteoglycan decorin was visualized with
immunocytochemistry; decorin (green), nuclei (blue). Negative control images in which
no primary antibody was added were used to set the threshold value for decorin
fluorescence. A) Low magnification negative control images. B) High magnification
negative control images.
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Appendix I: Influence of PCL electrospun scaffolds loaded with bFGF on decorin
and versican mRNA levels.
hGFs were seeded and cultured on PCL electrospun fibrous scaffolds with and without
bFGF microspheres for 1, 7 or 14 days. RNA was isolated and qRT-PCR was performed
using primers specific for decorin (DCN, Hs00754870_s1) and versican (VCAN,
HS00171642_m1). mRNA levels were normalized to endogenous 18S ribosomal RNA
levels. A) Release of bFGF from the microspheres did not significantly alter the levels of
decorin mRNA from that of the PCL alone scaffold. Decorin mRNA expression levels
showed a significant increase at 14 days on all scaffolds suggesting that decorin mRNA
expression is time dependent rather than bFGF dependent. B) Release of bFGF from the
microspheres significantly increased the level of versican mRNA expression at 14 days of
culture. Data are presented as mean ± SD of three independent experiments. Two-way
ANOVA with Bonferroni’s post-test was used to compare means. *p<0.05, **p<0.01,
#p<0.001.
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Appendix J: Collagen deposition in uninjured rat gingiva and immediately
following gingivectomy.
A) Van Gieson’s stain showing collagen (bright pink) in rat gingival tissue immediately
after gingivectomy. B) Van Gieson’s stain showing collagen (bright pink) in unwounded,
healthy rat gingival tissue. C) Masson’s trichrome stain showing collagen (blue) in rat
gingival tissue immediately after gingivectomy. D) Masson’s trichrome stain showing
collagen (blue) in unwounded, healthy rat gingival tissue.
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Appendix K: Myofibroblast population following in vivo gingivectomy.
Gingivectomy was performed in a rat model and defects were treated with scaffold
membranes of PCL alone, low bFGF loaded, high bFGF loaded or no treatment (empty
defect). Sections were labelled with a primary antibody for α-SMA and visualized with
DAB staining. A) Low magnification images. Scale bar = 200 µm. B) High
magnification images of the areas indicated by black boxes in A). Scale bar = 100 µm.
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Appendix L: No primary antibody negative control immunohistochemistry.
Negative control images in which no primary antibody was added were used to set the
threshold value for fluorescence in rat gingival wound sections. A) Negative control
image for arginase I immunofluorescence (cyan). B) Negative control image for α-SMA
immunofluorescence (red). C) Negative control image for PCNA immunofluorescence
(red). D) Negative control image for α-SMA immunohistochemistry. Scale bar = 200
µm.
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